Track market-moving stories before they get noisy

Clinical data from AbbVie's ABBV-1480 (RC148) PD-1/VEGF bispecific antibody in the frontline non-small cell lung cancer (NSCLC) setting will be presented via an oral presentation Additionally, new data and updates from AbbVie's telisotuzumab adizutecan (Temab-A) and ABBV-706 programs across NSCLC and small cell lung cancer (SCLC) to be shared Research reflects AbbVie's strategy aimed at building a lung cancer pipeline spanning next-generation immunotherapies, targeted antibody-drug conjugates (ADCs) and the potential for novel combination approaches , /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced new data highlighting research programs across its lung cancer portfolio being presented at the 2026 World Conference on Lung Cancer (WCLC), including non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). The presentations span clinical, translational and real-world data across next-generation immunotherapies and targeted antibody-drug conjugates (ADCs), designed to generate insights into treatment burden, patient experience and biomarker identification that may help inform future research.

"Our strategy in lung cancer is focused on building a complementary pipeline that brings together next-generation immunotherapies and targeted antibody-drug conjugates with the potential to address different aspects of tumor biology," said Daejin Abidoye, M.D., vice president and therapeutic area head of oncology, solid tumor and hematology at AbbVie. "Exploring the PD-1/VEGF approach represented by ABBV-1480 and the c-Met targeting by Temab-A are important elements of that strategy and may provide a foundation for potential novel combinations as we work to develop more tailored treatment approaches for people living with lung cancer."

Advancing Novel Therapies Across Various Modalities in NSCLC
Multiple presentations across AbbVie's NSCLC portfolio will showcase new studies and data analyses spanning multiple treatment modalities, highlighting first-line treatment approaches, patient experience and biomarker-informed research.

ABBV-1480 (RC148): AbbVie, in partnership with RemeGen, will present Phase 1b data evaluating the investigational PD-1/VEGF bispecific antibody, ABBV-1480, in combination with platinum-based chemotherapy as a potential first-line treatment for advanced NSCLC. At the 10 mg/kg dose, identified as the recommended Phase 3 dose for further development in combination regimens in both squamous and non-squamous NSCLC, the primary endpoint of objective response rate (ORR) was 90.0% in squamous NSCLC (n=27/30) and 75.9% (n=22/29) in non-squamous NSCLC. The most common treatment-related adverse events (TRAEs) were a decrease in white blood cells, neutrophil, platelet counts and anemia. No grade ≥3 hemorrhages with the 10 mg combinations were observed. This overall manageable safety profile supports ongoing Phase 3 development for this novel investigational asset.1  Telisotuzumab adizutecan (Temab-A), an investigational c-Met-directed ADC with a topoisomerase 1 inhibitor (Top1i) payload: Building on encouraging preliminary activity2 observed in heavily pretreated patients, AbbVie initiated a Phase 1b/2 M24-536 study (NCT06772623). The study is evaluating a platinum-free combination of Temab-A and a PD-1 inhibitor, as a potential first-line treatment for advanced non-squamous NSCLC. The study includes analyses of c-Met and PD-L1 expression to identify the patients most likely to benefit from treatment.3 Temab-A is also being studied in epidermal growth factor receptor (EGFR)-mutated NSCLC as monotherapy or in combination with osimertinib (NCT07155187). Clinical Data Showcasing the Potential of ABBV-706 in SCLC
ABBV-706 is an investigational SEZ6-targeted ADC with a Top1i payload, being evaluated in SCLC. Presentations at WCLC include research that further characterizes the program and the potential role of SEZ6 in SCLC.

As previously reported, ABBV-706 demonstrated an ORR of 82% in patients with relapsed/refractory SCLC post platinum-based chemotherapy (n=17).4 New safety analyses from 240 patients who received ABBV-706 monotherapy showed generally manageable hematologic and gastrointestinal toxicities, with the most common gastrointestinal events, including nausea (35.8%), vomiting (17.5%) and diarrhea (10.8%), being largely low grade and most requiring no dose adjustments.5 Grade ≥3 treatment-related pneumonitis or interstitial lung disease was reported in 1.7% of patients receiving ABBV-706 monotherapy.6 Hematologic toxicities, including anemia, neutropenia and thrombocytopenia, were among the most common TRAEs.5 Serious TRAEs occurred in 12.5% of patients. ABBV-706 is being evaluated as monotherapy in a Phase 3 study (NCT07365241) and in combination with atezolizumab in the Phase 2 study (NCT07155174), in SCLC. Real-world research demonstrated that SEZ6 is broadly expressed in 91% of SCLC patients overall and in more than 96% of patients with brain or liver metastases. These findings further support SEZ6 as a potential therapeutic target in SCLC and other SEZ6-expressing tumors. 7  Additional details on key presentations are available below, and the full WCLC 2026 abstracts are available online.

For information about AbbVie's clinical trial efforts in lung cancer, please visit clinicaltrials.gov. 

Title

Date/Time

Session                         

Abstract Number     

Radiomic Biomarkers on Baseline CT

Scans for Predicting Response to

Teliso-V in NSCLC: A Machine

Learning Approach

Monday,
September 14

10:30AM-12:00PM KST

Poster

Session: P2.077-248.

Pathology and
Biomarkers

P2.137.

Telisotuzumab Adizutecan and PD-1 Inhibitor

in Untreated Advanced Non-Squamous

Non-Small Cell Lung Cancer: A Phase

1b/2 Study

Monday,
September 14

10:30AM-12:00PM KST

Poster

Session: P2.304-390.

Clinical Trials in
Progress

P2.374.

Efficacy and Safety of ABBV-706 Versus

Standard of Care in Relapsed/Refractory

 Small Cell Lung Cancer: A Phase 3 Study

Monday,
September 14

10:30AM-12:00PM KST

Poster

Session: P2.304-390.

Clinical Trials in
Progress

P2.377.

A Phase 3, Randomized, Double-Blind Trial

of RC148 (ABBV-1480) Plus Chemotherapy

in First-Line Squamous Non-Small-Cell

Lung Cancer

Monday,

September 14

10:30AM-12:00PM KST

Poster

Session: P2.304-390.

Clinical Trials in
Progress

P2.379.

Peripheral Neuropathy With Teliso-V in

c-Met- Protein Overexpressing NSCLC

in LUMINOSITY: Clinical Characteristics

and PROs

Monday,

September 14

2:17-2:25 PM KST

Poster

Session: PT2.01.

Metastatic
NSCLC –
Antibody-Drug
Conjugate and
Cytotoxic
Therapy

PT2.01.05.

Telisotuzumab vedotin Demonstrates Potent

Antitumor Efficacy in Preclinical Models of

Diffuse Pleural Mesothelioma

Monday,

September 14

2:17-2:25 PM KST

Poster

Session: PT2.05.

Mesothelioma,
Thymoma, and
Other Thoracic
Tumors

PT2.05.05.

Hematologic and Gastrointestinal Toxicity of

ABBV-706 in Advanced Solid Tumors: Safety

Profile from the First-in-Human Study

Tuesday,

September 15

9:30-11:00 AM KST

Poster

Session: P3.282-354.

Small Cell Lung
Cancer and
Neuroendocrine
Tumors

P3.316.

SEZ6 Is Expressed Across Major Clinical and

Demographic Groups of SCLC Patients:

Evidence From a US Clinicogenomic

Database

Tuesday,

September 15 

9:30 AM-11:00 AM KST

Poster

Session: P3.282-354.

Small Cell Lung
Cancer and
Neuroendocrine
Tumors

P3.340.

RC148 (ABBV-1480, PD-1/VEGF Bispecific

Antibody) Plus Chemotherapy in First-Line

Locally Advanced or Metastatic Non-Small-

Cell Lung Cancer

Tuesday,

September 15

12:52-1:02 PM KST

Oral Presentation

Session: OA14.

The Breakthrough
Immunotherapy
for Advanced
NSCLC

OA14.01.03.

High Burden and Limited Evidence in Late-

Line ES-SCLC: A Structured Review of

Clinical and Humanistic Outcomes

-

E-Poster

EP13 Small Cell
Lung Cancer and
Neuroendocrine
Tumors

EP13.05.

Pneumonitis/Interstitial Lung Disease in the

First-in-Human ABBV-706 Study: Incidence,

Management, and Risk Factors

-

E-Poster

EP13 Small Cell
Lung Cancer and
Neuroendocrine
Tumors

EP13.32.

Telisotuzumab adizutecan (Temab-A) and ABBV-706 are investigational medicines and are not approved by any health authorities worldwide. The safety and efficacy of these investigational medicines are under evaluation as part of ongoing clinical studies.

AbbVie holds exclusive rights from RemeGen to develop, manufacture, and commercialize ABBV-1480 outside of the Greater China territory.

Emrelis™ (telisotuzumab vedotin-tllv) is an approved medicine being investigated for additional uses. Safety and efficacy have not been established for these unapproved additional uses.

U.S. Prescribing Information for AbbVie Medicines
Please see full Prescribing Information for EMRELIS™ (telisotuzumab vedotin-tllv).

About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.

About AbbVie in Oncology 
AbbVie is committed to elevating standards of care and bringing transformative therapies to patients worldwide living with difficult-to-treat cancers. We are advancing a dynamic pipeline of investigational therapies across a range of cancer types in both blood cancers and solid tumors. We are focusing on creating targeted medicines that either impede the reproduction of cancer cells or enable their elimination. We achieve this through various, targeted treatment modalities and biology interventions, including small molecule therapeutics, antibody-drug conjugates (ADCs), immuno-oncology-based therapeutics, multispecific antibody and novel CAR-T platforms. Our dedicated and experienced team joins forces with innovative partners to accelerate the delivery of potential breakthrough medicines. 

Today, our expansive oncology portfolio comprises approved and investigational treatments for a wide range of blood cancers and solid tumors. We are evaluating more than 35 investigational medicines in multiple clinical trials across some of the world's most widespread and debilitating cancers. As we work to have a remarkable impact on people's lives, we are committed to exploring solutions to help patients obtain access to our cancer medicines. For more information, please visit http://www.abbvie.com/oncology. 

Forward-Looking Statements
Some statements in this news release are, or may be considered, forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. The words "believe," "expect," "anticipate," "project" and similar expressions and uses of future or conditional verbs, generally identify forward-looking statements. AbbVie cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. Such risks and uncertainties include, but are not limited to, challenges to intellectual property, competition from other products, difficulties inherent in the research and development process, adverse litigation or government action, changes to laws and regulations applicable to our industry, the impact of global macroeconomic factors, such as economic downturns or uncertainty, international conflict, trade disputes and tariffs, and other uncertainties and risks associated with global business operations. Additional information about the economic, competitive, governmental, technological and other factors that may affect AbbVie's operations is set forth in Item 1A, "Risk Factors," of AbbVie's 2025 Annual Report on Form 10-K, which has been filed with the Securities and Exchange Commission, as updated by its Quarterly Reports on Form 10-Q and in other documents that AbbVie subsequently files with the Securities and Exchange Commission that update, supplement or supersede such information. AbbVie undertakes no obligation, and specifically declines, to release publicly any revisions to forward-looking statements as a result of subsequent events or developments, except as required by law.

References:

Zhang L, Zhao Y, Fan Y, et al. RC148 (ABBV-1480, PD-1/VEGF bispecific antibody) plus chemotherapy in first-line locally advanced or metastatic non-small cell lung cancer. Abstract OA14.01.03. presented at the World Conference on Lung Cancer, 2026. Seoul, Republic of Korea. De Miguel M, Yamamoto N, Raimbourg J, et al. ABBV-400, a c-Met protein-targeting antibody-drug conjugate (ADC), in patients with advanced EGFR wild-type non-squamous non-small cell lung cancer: results from a phase I study. Ann Oncol. 2024;35(Suppl):S805-S806. Abstract 1257MO. Horinouchi H, Cuppens K, Camidge DR, et al. Telisotuzumab adizutecan and PD-1 inhibitor in untreated advanced non-squamous non-small cell lung cancer: a phase 1b/2 study. Abstract P2.374. presented at the World Conference on Lung Cancer, 2026. Seoul, Republic of Korea. Byers LA, Cho BC, Cooper AJ, et al. ABBV-706 as monotherapy and in combination with budigalimab in patients with relapsed/refractory (R/R) small cell lung cancer (SCLC). J Clin Oncol 44, 8008-8008 (2026). Chiang AC, Byers LA, Cooper AJ, et al. Hematologic and Gastrointestinal Toxicity of ABBV-706 in Advanced Solid Tumors: Safety Profile from the First-in-Human Study. Abstract P3.316. presented at the World Conference on Lung Cancer, 2026. Seoul, Republic of Korea. Paz-Ares L, Chandana S, Chiang AC, et al. Pneumonitis/Interstitial Lung Disease in the First-in-Human ABBV-706 Study: Incidence, Management, and Risk Factors. E-Poster EP13.32. presented at the World Conference on Lung Cancer, 2026. Seoul, Republic of Korea. Jahchan N, Calip GS, Guadamuz JS, et al. SEZ6 is expressed across major clinical and demographic groups of SCLC patients: evidence from a US clinicogenomic database. Abstract P3.340. presented at the World Conference on Lung Cancer, 2026. Seoul, Republic of Korea.  SOURCE AbbVie

Advisors Capital Management LLC purchased a new stake in shares of Bristol Myers Squibb Company (NYSE:BMY – Free Report) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 1,029,843 shares of the biopharmaceutical company’s stock, valued at approximately $59,340,000. Advisors Capital Management LLC owned about 0.05% of Bristol Myers Squibb at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in the business. MJP Associates Inc. ADV purchased a new position in Bristol Myers Squibb in the 2nd quarter worth $322,000. PCM Encore LLC purchased a new stake in Bristol Myers Squibb during the second quarter valued at about $313,000. Vise Technologies Inc. purchased a new stake in Bristol Myers Squibb during the second quarter valued at about $8,177,000. OVERSEA CHINESE BANKING Corp Ltd bought a new position in shares of Bristol Myers Squibb during the second quarter valued at about $1,559,000. Finally, E Fund Management Co. Ltd. purchased a new position in shares of Bristol Myers Squibb in the second quarter worth about $742,000. 76.41% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades A number of equities research analysts have recently weighed in on the company. Raymond James Financial started coverage on Bristol Myers Squibb in a research note on Wednesday, August 5th. They issued a “strong-buy” rating for the company. Jefferies Financial Group cut Bristol Myers Squibb from a “buy” rating to a “hold” rating in a research note on Wednesday, August 5th. Guggenheim reiterated a “buy” rating and issued a $75.00 price objective (up from $72.00) on shares of Bristol Myers Squibb in a research report on Friday, July 31st. Argus raised Bristol Myers Squibb from a “hold” rating to a “buy” rating and set a $75.00 price objective for the company in a research note on Wednesday, August 5th. Finally, Citigroup restated a “neutral” rating and issued a $70.00 target price (up from $66.00) on shares of Bristol Myers Squibb in a report on Monday, August 3rd. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $66.06.

Get Our Latest Research Report on Bristol Myers Squibb Key Stories Impacting Bristol Myers Squibb Here are the key news stories impacting Bristol Myers Squibb this week:

Positive Sentiment: Bristol Myers Squibb announced a collaboration with Chai Discovery to use artificial intelligence for antibody discovery. The partnership could improve the speed and efficiency of developing new therapies, although financial terms and the near-term earnings impact were not disclosed. Chai Discovery collaboration with Bristol Myers Squibb Positive Sentiment: An update on the Phase 1 study of navlimetostat indicates continued progress in Bristol Myers Squibb’s early-stage pipeline. The program remains experimental, so any commercial benefit is still distant and uncertain. Bristol Myers Squibb navlimetostat study update Positive Sentiment: Hematogenix said its minimal residual disease assay supported the FDA’s accelerated approval of Bristol Myers Squibb’s ZENBEXUS™, described as the first approved CELMoD therapy for multiple myeloma. The approval could expand the company’s oncology opportunity, though accelerated approvals typically require confirmatory evidence. Hematogenix assay and ZENBEXUS approval Positive Sentiment: Unusually heavy call-option activity, with 55,757 calls purchased—more than double the average volume—signals increased speculative interest in BMY. Options activity is not confirmation of a sustained rally and can increase volatility. Positive Sentiment: Analyst coverage continues to characterize BMY as an attractive value stock, supported by its relatively low valuation and income potential. A separate comparison also frames Bristol Myers Squibb as a potential bargain versus AstraZeneca, though these are opinion-based assessments. Zacks BMY value-stock analysis Neutral Sentiment: Articles discussing a covered-call strategy emphasize income generation rather than a bullish outlook for capital appreciation. The strategy may appeal to yield-focused investors but can limit upside if the shares rise sharply. Bristol Myers Squibb options income strategy Neutral Sentiment: A report on Aktis Oncology, which has attracted interest from Bristol Myers Squibb and other large pharmaceutical companies, highlights potential future deal activity but does not announce a transaction or create an immediate financial impact for BMY. Pharmaceutical interest in Aktis Oncology Bristol Myers Squibb Trading Down 3.1% BMY opened at $65.54 on Friday. Bristol Myers Squibb Company has a one year low of $42.52 and a one year high of $68.64. The company has a debt-to-equity ratio of 1.89, a current ratio of 1.53 and a quick ratio of 1.38. The business has a 50 day simple moving average of $60.35 and a two-hundred day simple moving average of $59.31. The firm has a market capitalization of $133.88 billion, a price-to-earnings ratio of 14.44, a PEG ratio of 0.18 and a beta of 0.22.

Bristol Myers Squibb (NYSE:BMY – Get Free Report) last issued its quarterly earnings data on Thursday, July 30th. The biopharmaceutical company reported $2.04 earnings per share for the quarter, topping analysts’ consensus estimates of $1.60 by $0.44. The firm had revenue of $12.97 billion for the quarter, compared to analyst estimates of $11.74 billion. Bristol Myers Squibb had a return on equity of 66.90% and a net margin of 18.87%.The business’s quarterly revenue was up 5.7% compared to the same quarter last year. During the same period last year, the company earned $1.46 EPS. Bristol Myers Squibb has set its FY 2026 guidance at 6.750-7.000 EPS. Analysts predict that Bristol Myers Squibb Company will post 6.95 EPS for the current year.

Bristol Myers Squibb Dividend Announcement The business also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 2nd were issued a $0.63 dividend. The ex-dividend date was Thursday, July 2nd. This represents a $2.52 annualized dividend and a yield of 3.8%. Bristol Myers Squibb’s dividend payout ratio (DPR) is 55.51%.

Bristol Myers Squibb Profile (Free Report)

Bristol Myers Squibb is a global biopharmaceutical company headquartered in Princeton, New Jersey, focused on discovering, developing and delivering medicines for serious diseases. The company’s core activities include research and development, clinical development, manufacturing and commercialization of prescription pharmaceuticals across multiple therapeutic areas. BMS concentrates on advancing therapies in oncology, hematology, immunology, cardiovascular disease and specialty areas through both small molecules and biologics.

BMS’s marketed portfolio and late‑stage pipeline reflect a strong emphasis on cancer and immune‑mediated conditions.

See Also Five stocks we like better than Bristol Myers Squibb 3 Energy Stocks Raising Dividends as the Sector Surges 5 Reasons the S&P 500 Could Keep Rallying Through Year-End Walmart’s Post-Earnings Drop Could Be a Buying Opportunity The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future Want to see what other hedge funds are holding BMY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bristol Myers Squibb Company (NYSE:BMY – Free Report).

Receive News & Ratings for Bristol Myers Squibb Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bristol Myers Squibb and related companies with MarketBeat.com's FREE daily email newsletter.

Bank of New York Mellon Corp decreased its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 2.6% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,695,586 shares of the medical research company’s stock after selling 97,857 shares during the quarter. Bank of New York Mellon Corp owned 0.68% of Amgen worth $1,338,246,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the company. Adell Harriman & Carpenter Inc. lifted its stake in Amgen by 7.9% in the 4th quarter. Adell Harriman & Carpenter Inc. now owns 22,008 shares of the medical research company’s stock valued at $7,204,000 after purchasing an additional 1,609 shares during the last quarter. Fideuram Intesa Sanpaolo Private Banking S.P.A. bought a new stake in Amgen in the fourth quarter valued at approximately $22,441,000. Sigma Planning Corp raised its stake in Amgen by 24.0% in the fourth quarter. Sigma Planning Corp now owns 17,992 shares of the medical research company’s stock valued at $5,889,000 after buying an additional 3,488 shares during the period. National Pension Service lifted its position in shares of Amgen by 4.7% in the fourth quarter. National Pension Service now owns 1,239,549 shares of the medical research company’s stock valued at $405,717,000 after buying an additional 55,489 shares during the last quarter. Finally, Integrated Advisors Network LLC boosted its stake in shares of Amgen by 50.5% during the 1st quarter. Integrated Advisors Network LLC now owns 18,941 shares of the medical research company’s stock worth $6,664,000 after acquiring an additional 6,356 shares during the period. 76.50% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades AMGN has been the subject of several research reports. Oppenheimer raised their price target on Amgen from $400.00 to $450.00 and gave the company an “outperform” rating in a report on Wednesday, August 5th. Cantor Fitzgerald lifted their target price on shares of Amgen from $350.00 to $400.00 and gave the stock a “neutral” rating in a report on Tuesday. Mizuho upped their price target on shares of Amgen from $303.00 to $352.00 and gave the company a “neutral” rating in a research note on Tuesday. TD Cowen increased their price target on shares of Amgen from $420.00 to $452.00 and gave the company a “buy” rating in a report on Wednesday, August 5th. Finally, Truist Financial raised their price objective on shares of Amgen from $340.00 to $362.00 and gave the stock a “hold” rating in a research report on Wednesday, August 5th. One research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating, fourteen have assigned a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $380.43.

Read Our Latest Stock Report on AMGN Amgen News Summary Here are the key news stories impacting Amgen this week:

Positive Sentiment: Unusually heavy call-option activity points to increased bullish positioning. Investors purchased 79,035 call options, roughly 931% above typical volume, although options activity is speculative and does not guarantee future gains. Positive Sentiment: Argus raised its price target from $375 to $460 and upgraded Amgen to “Buy,” adding to the series of favorable analyst views. Argus price target report Positive Sentiment: Mizuho and Cantor Fitzgerald analysts also projected further appreciation for Amgen, reinforcing the bullish sentiment around the company’s earnings performance and pipeline. Mizuho Amgen forecast Cantor Fitzgerald Amgen outlook Positive Sentiment: Amgen has outperformed several major drugmakers in 2026, attracting investor interest as markets favor profitable pharmaceutical companies even without an obesity-drug franchise. Drugmaker stock performance comparison Neutral Sentiment: Biotech ETFs are benefiting from innovation, obesity-drug demand and merger activity, creating a favorable sector backdrop, though the article does not identify a specific new catalyst for Amgen. Biotech ETF growth article Negative Sentiment: Industry caution around obesity-drug development is a risk: investors are penalizing undifferentiated programs, and Amgen has reportedly trimmed some early-stage efforts. Obesity drug investment outlook Amgen Stock Performance NASDAQ:AMGN opened at $433.73 on Friday. Amgen Inc. has a fifty-two week low of $269.77 and a fifty-two week high of $443.20. The stock has a fifty day moving average price of $377.35 and a 200-day moving average price of $361.40. The company has a debt-to-equity ratio of 4.44, a quick ratio of 1.13 and a current ratio of 1.37. The company has a market cap of $234.49 billion, a price-to-earnings ratio of 26.96, a PEG ratio of 4.09 and a beta of 0.41.

Amgen (NASDAQ:AMGN – Get Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The medical research company reported $6.29 EPS for the quarter, topping analysts’ consensus estimates of $5.62 by $0.67. Amgen had a return on equity of 124.14% and a net margin of 22.95%.The company had revenue of $10.05 billion during the quarter, compared to analysts’ expectations of $9.43 billion. During the same quarter in the previous year, the firm earned $6.02 EPS. Amgen’s revenue was up 9.5% on a year-over-year basis. Amgen has set its FY 2026 guidance at 22.300-23.500 EPS. As a group, equities analysts anticipate that Amgen Inc. will post 22.89 EPS for the current fiscal year.

Amgen Announces Dividend The company also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Friday, August 21st will be issued a $2.52 dividend. The ex-dividend date is Friday, August 21st. This represents a $10.08 annualized dividend and a yield of 2.3%. Amgen’s payout ratio is presently 62.65%.

Insider Transactions at Amgen In other Amgen news, SVP Nancy A. Grygiel sold 2,970 shares of Amgen stock in a transaction dated Thursday, August 6th. The stock was sold at an average price of $402.16, for a total transaction of $1,194,415.20. Following the completion of the sale, the senior vice president owned 7,340 shares of the company’s stock, valued at $2,951,854.40. The trade was a 28.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Rachna Khosla sold 2,000 shares of the company’s stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $412.57, for a total value of $825,140.00. Following the completion of the transaction, the senior vice president owned 6,404 shares of the company’s stock, valued at $2,642,098.28. The trade was a 23.80% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 6,222 shares of company stock worth $2,540,926 over the last three months. 0.85% of the stock is owned by company insiders.

About Amgen (Free Report)

Amgen Inc (NASDAQ: AMGN) is a global biotechnology company founded in 1980 and headquartered in Thousand Oaks, California. The company focuses on discovering, developing, manufacturing and delivering human therapeutics that address serious illnesses. Amgen’s work centers on biologic medicines derived from cellular and molecular biology, with an emphasis on translating advances in human genetics and protein science into therapies for patients.

Amgen’s commercial portfolio has historically included biologics used in oncology, supportive care, nephrology, bone health and cardiovascular disease.

Further Reading Five stocks we like better than Amgen 3 Energy Stocks Raising Dividends as the Sector Surges 5 Reasons the S&P 500 Could Keep Rallying Through Year-End Walmart’s Post-Earnings Drop Could Be a Buying Opportunity The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future

Receive News & Ratings for Amgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amgen and related companies with MarketBeat.com's FREE daily email newsletter.

Asahi Life Asset Management CO. LTD. acquired a new position in shares of Philip Morris International Inc. (NYSE:PM – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 4,464 shares of the company’s stock, valued at approximately $808,000.

A number of other hedge funds also recently bought and sold shares of PM. AG Campbell Advisory LLC purchased a new position in shares of Philip Morris International in the fourth quarter worth approximately $25,000. Caitong International Asset Management Co. Ltd purchased a new stake in shares of Philip Morris International in the 2nd quarter valued at approximately $29,000. Portfolio Resources Advisor Group Inc. purchased a new stake in shares of Philip Morris International in the 4th quarter valued at approximately $26,000. Vermillion Wealth Management Inc. boosted its stake in Philip Morris International by 146.5% in the 1st quarter. Vermillion Wealth Management Inc. now owns 175 shares of the company’s stock worth $29,000 after purchasing an additional 104 shares during the period. Finally, Safe Harbor Fiduciary LLC acquired a new position in Philip Morris International in the 4th quarter worth approximately $29,000. 78.63% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth PM has been the topic of several recent analyst reports. Needham & Company LLC boosted their target price on shares of Philip Morris International from $200.00 to $215.00 and gave the company a “buy” rating in a research note on Thursday, July 23rd. Barclays raised their target price on Philip Morris International from $205.00 to $225.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 29th. Morgan Stanley upped their price target on Philip Morris International from $200.00 to $215.00 and gave the company an “overweight” rating in a research report on Thursday, July 23rd. Bank of America reissued a “buy” rating on shares of Philip Morris International in a research note on Thursday, May 21st. Finally, Stifel Nicolaus raised their price objective on Philip Morris International from $195.00 to $205.00 and gave the stock a “buy” rating in a research report on Thursday, July 23rd. Ten analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $205.89.

Check Out Our Latest Stock Report on Philip Morris International Philip Morris International Price Performance NYSE PM opened at $191.85 on Friday. Philip Morris International Inc. has a fifty-two week low of $142.11 and a fifty-two week high of $207.76. The stock’s 50-day moving average is $185.96 and its two-hundred day moving average is $178.30. The firm has a market cap of $299.02 billion, a P/E ratio of 27.56, a price-to-earnings-growth ratio of 2.29 and a beta of 0.38.

Philip Morris International (NYSE:PM – Get Free Report) last issued its quarterly earnings data on Wednesday, July 22nd. The company reported $2.20 earnings per share for the quarter, topping analysts’ consensus estimates of $2.05 by $0.15. The business had revenue of $11.19 billion during the quarter, compared to analysts’ expectations of $10.60 billion. Philip Morris International had a net margin of 11.06% and a negative return on equity of 163.41%. Philip Morris International’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same period in the previous year, the company earned $1.89 earnings per share. Philip Morris International has set its Q3 2026 guidance at 2.200-2.25 EPS. On average, equities analysts expect that Philip Morris International Inc. will post 8.33 EPS for the current year.

Philip Morris International Dividend Announcement The firm also recently disclosed a quarterly dividend, which was paid on Monday, July 20th. Investors of record on Thursday, June 25th were given a dividend of $1.47 per share. This represents a $5.88 annualized dividend and a dividend yield of 3.1%. The ex-dividend date of this dividend was Thursday, June 25th. Philip Morris International’s payout ratio is currently 84.48%.

(Free Report)

Philip Morris International Inc (NYSE: PM) is a global tobacco company that manufactures and sells cigarettes, other nicotine-containing products and a growing portfolio of smoke-free alternatives for adult smokers. The firm traces its corporate roots to the 19th century Philip Morris enterprise and was established as an independent, publicly traded company following a 2008 separation from what is now Altria. Since the spin-off, the company has focused on serving international markets outside the United States.

PMI’s product mix includes traditional combustible cigarettes as well as smoke-free offerings such as heated tobacco systems and other reduced-risk products.

Featured Articles Five stocks we like better than Philip Morris International 3 Energy Stocks Raising Dividends as the Sector Surges 5 Reasons the S&P 500 Could Keep Rallying Through Year-End Walmart’s Post-Earnings Drop Could Be a Buying Opportunity The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future

Receive News & Ratings for Philip Morris International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Philip Morris International and related companies with MarketBeat.com's FREE daily email newsletter.

Bank of New York Mellon Corp bought a new stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 3,938,410 shares of the medical research company’s stock, valued at approximately $1,974,561,000. Bank of New York Mellon Corp owned approximately 1.07% of Thermo Fisher Scientific as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of TMO. Brighton Jones LLC boosted its holdings in Thermo Fisher Scientific by 28.9% in the 4th quarter. Brighton Jones LLC now owns 4,409 shares of the medical research company’s stock valued at $2,293,000 after purchasing an additional 988 shares during the last quarter. Revolve Wealth Partners LLC raised its position in shares of Thermo Fisher Scientific by 4.2% during the 4th quarter. Revolve Wealth Partners LLC now owns 491 shares of the medical research company’s stock valued at $255,000 after buying an additional 20 shares during the period. Darwin Wealth Management LLC acquired a new position in Thermo Fisher Scientific in the second quarter valued at approximately $170,000. Raymond James Financial Inc. grew its position in Thermo Fisher Scientific by 7.4% in the second quarter. Raymond James Financial Inc. now owns 778,822 shares of the medical research company’s stock worth $315,781,000 after acquiring an additional 53,542 shares during the period. Finally, California State Teachers Retirement System increased its stake in Thermo Fisher Scientific by 0.4% during the second quarter. California State Teachers Retirement System now owns 602,031 shares of the medical research company’s stock worth $244,099,000 after acquiring an additional 2,262 shares during the last quarter. Hedge funds and other institutional investors own 89.23% of the company’s stock.

Insider Buying and Selling
In related news, COO Gianluca Pettiti sold 400 shares of the firm’s stock in a transaction that occurred on Monday, July 27th. The shares were sold at an average price of $565.00, for a total value of $226,000.00. Following the sale, the chief operating officer owned 24,651 shares of the company’s stock, valued at $13,927,815. This trade represents a 1.60% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael D. Shafer sold 25,500 shares of the business’s stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $600.00, for a total transaction of $15,300,000.00. Following the transaction, the executive vice president owned 20,994 shares of the company’s stock, valued at approximately $12,596,400. The trade was a 54.85% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 63,493 shares of company stock worth $37,657,681 over the last ninety days. Company insiders own 0.33% of the company’s stock.

Analyst Ratings Changes
A number of equities analysts have recently weighed in on the company. Morgan Stanley increased their price target on Thermo Fisher Scientific from $620.00 to $650.00 and gave the stock an “overweight” rating in a report on Friday, July 24th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $630.00 target price on shares of Thermo Fisher Scientific in a research report on Thursday, July 23rd. Wells Fargo & Company lowered their target price on shares of Thermo Fisher Scientific from $675.00 to $615.00 and set an “overweight” rating for the company in a research note on Friday, May 8th. Robert W. Baird reduced their price target on shares of Thermo Fisher Scientific from $653.00 to $639.00 and set an “outperform” rating on the stock in a research note on Friday, April 24th. Finally, Barclays upped their price objective on shares of Thermo Fisher Scientific from $625.00 to $650.00 and gave the stock an “overweight” rating in a report on Friday, July 24th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $619.41.
Check Out Our Latest Stock Report on Thermo Fisher Scientific

Thermo Fisher Scientific Stock Performance
NYSE TMO opened at $628.24 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.55 and a quick ratio of 1.18. The company has a market cap of $232.29 billion, a P/E ratio of 33.79, a P/E/G ratio of 2.50 and a beta of 0.85. The stock has a 50-day moving average of $539.33 and a two-hundred day moving average of $508.86. Thermo Fisher Scientific Inc. has a 1-year low of $435.27 and a 1-year high of $643.99.

Thermo Fisher Scientific (NYSE:TMO – Get Free Report) last issued its quarterly earnings results on Thursday, July 23rd. The medical research company reported $6.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.71 by $0.32. Thermo Fisher Scientific had a net margin of 15.04% and a return on equity of 17.09%. The business had revenue of $11.99 billion for the quarter, compared to analysts’ expectations of $11.71 billion. During the same quarter in the prior year, the company earned $4.28 earnings per share. The business’s quarterly revenue was up 10.5% on a year-over-year basis. Thermo Fisher Scientific has set its FY 2026 guidance at 24.930-25.330 EPS. As a group, analysts anticipate that Thermo Fisher Scientific Inc. will post 25.12 EPS for the current year.

Thermo Fisher Scientific Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Tuesday, September 15th will be issued a dividend of $0.47 per share. The ex-dividend date is Tuesday, September 15th. This represents a $1.88 annualized dividend and a yield of 0.3%. Thermo Fisher Scientific’s dividend payout ratio is 10.11%.

(Free Report)

Thermo Fisher Scientific (NYSE: TMO) is a global provider of scientific instrumentation, reagents and consumables, software, and services that support research, clinical, and industrial laboratories. The company supplies analytical instruments and laboratory equipment, life sciences reagents and kits, specialty diagnostics, and a broad range of consumables used by researchers, clinicians, and manufacturers. Its offerings also include laboratory information management and data-analysis software, as well as service solutions such as instrument maintenance, validation, and logistics that help customers run complex workflows efficiently.

Thermo Fisher operates through multiple business areas that broadly cover life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services, including contract development and manufacturing for pharmaceutical and biotechnology companies.

Read More

Five stocks we like better than Thermo Fisher Scientific
3 Energy Stocks Raising Dividends as the Sector Surges
5 Reasons the S&P 500 Could Keep Rallying Through Year-End
Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report).

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

Bank of New York Mellon Corp purchased a new stake in Lockheed Martin Corporation (NYSE:LMT – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 1,266,551 shares of the aerospace company’s stock, valued at approximately $645,258,000. Bank of New York Mellon Corp owned 0.55% of Lockheed Martin at the end of the most recent reporting period.

A number of other institutional investors have also recently modified their holdings of LMT. Charles Schwab Investment Management Inc. increased its position in Lockheed Martin by 1.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 8,638,936 shares of the aerospace company’s stock worth $4,178,399,000 after buying an additional 114,900 shares in the last quarter. Morgan Stanley lifted its position in shares of Lockheed Martin by 10.1% in the fourth quarter. Morgan Stanley now owns 5,728,551 shares of the aerospace company’s stock valued at $2,770,729,000 after acquiring an additional 527,523 shares in the last quarter. Franklin Resources Inc. lifted its position in shares of Lockheed Martin by 0.6% in the fourth quarter. Franklin Resources Inc. now owns 1,670,284 shares of the aerospace company’s stock valued at $807,866,000 after acquiring an additional 10,349 shares in the last quarter. Deutsche Bank AG boosted its stake in shares of Lockheed Martin by 7.4% during the fourth quarter. Deutsche Bank AG now owns 1,440,840 shares of the aerospace company’s stock valued at $696,891,000 after acquiring an additional 99,403 shares during the last quarter. Finally, AQR Capital Management LLC boosted its stake in shares of Lockheed Martin by 107.3% during the fourth quarter. AQR Capital Management LLC now owns 1,293,823 shares of the aerospace company’s stock valued at $625,784,000 after acquiring an additional 669,604 shares during the last quarter. 74.19% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In Several brokerages recently weighed in on LMT. JPMorgan Chase & Co. cut their target price on shares of Lockheed Martin from $680.00 to $605.00 and set a “neutral” rating for the company in a research note on Tuesday, May 5th. Citigroup raised their price target on shares of Lockheed Martin from $641.00 to $691.00 and gave the stock a “buy” rating in a research note on Thursday, August 13th. BNP Paribas Exane lowered their price target on shares of Lockheed Martin from $770.00 to $680.00 and set an “outperform” rating for the company in a report on Friday, April 24th. Weiss Ratings raised shares of Lockheed Martin from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, August 13th. Finally, Deutsche Bank Aktiengesellschaft reduced their price objective on shares of Lockheed Martin from $615.00 to $575.00 and set a “hold” rating on the stock in a research note on Friday, April 24th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, ten have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $632.39.

View Our Latest Stock Report on Lockheed Martin Lockheed Martin Price Performance Lockheed Martin stock opened at $571.60 on Friday. Lockheed Martin Corporation has a 1 year low of $437.25 and a 1 year high of $692.00. The firm has a 50 day moving average price of $547.31 and a 200 day moving average price of $575.81. The company has a market cap of $131.92 billion, a price-to-earnings ratio of 21.07, a PEG ratio of 1.01 and a beta of 0.10. The company has a debt-to-equity ratio of 2.34, a quick ratio of 1.01 and a current ratio of 1.19.

Lockheed Martin (NYSE:LMT – Get Free Report) last announced its quarterly earnings results on Thursday, July 23rd. The aerospace company reported $7.94 earnings per share for the quarter, beating analysts’ consensus estimates of $7.22 by $0.72. Lockheed Martin had a net margin of 8.16% and a return on equity of 91.42%. The company had revenue of $20.06 billion for the quarter, compared to analyst estimates of $19.34 billion. During the same quarter last year, the business earned $1.46 EPS. Lockheed Martin’s revenue for the quarter was up 10.5% on a year-over-year basis. Lockheed Martin has set its FY 2026 guidance at 29.950-30.650 EPS. Sell-side analysts predict that Lockheed Martin Corporation will post 30.39 earnings per share for the current year.

Lockheed Martin Announces Dividend The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Tuesday, September 1st will be paid a dividend of $3.45 per share. This represents a $13.80 annualized dividend and a yield of 2.4%. The ex-dividend date is Tuesday, September 1st. Lockheed Martin’s payout ratio is currently 50.87%.

Lockheed Martin News Summary Here are the key news stories impacting Lockheed Martin this week:

Positive Sentiment: Lockheed Martin completed the first fully integrated Aegis System Equipped Vessel for Japan, a milestone that expands its role in Japan’s maritime air- and missile-defense infrastructure and supports broader Indo-Pacific defense cooperation. The achievement could strengthen the company’s position for future naval and missile-defense contracts. Lockheed Martin Completes First Japan ASEV In Indo Pacific Defense Milestone Positive Sentiment: Recent activity involving AI-enabled airspace sensing, next-generation missile-defense testing, modular defense systems and responsive space-launch partnerships adds to Lockheed Martin’s growth narrative. The company and its partners also participated in more than $152 million of recent Department of Defense contracts and a $920 million Air Force award pool. Should Lockheed’s AI Sensing and Space Partnerships Shift the Core Investment Case for LMT? Positive Sentiment: A valuation analysis argued that LMT may be approximately 24% undervalued based on discounted-cash-flow and comparable-multiple measures, despite an 87.9% five-year return. This may support the view that long-term defense demand is not fully reflected in the shares. Lockheed Martin Stock May Be 24% Undervalued On Japan Defense System News Neutral Sentiment: Commentary highlighted a potential new entry point in the military naval market, but the reports did not indicate a material near-term revenue or earnings contribution. Why Did Lockheed Martin Stock Drop Today? Neutral Sentiment: Speculation that Lockheed Martin could split its stock if it returns to its recent high is not a fundamental catalyst; a split would change the share count and price denomination, but not the company’s value. Stock-Split Watch: Is Lockheed Martin Next? Lockheed Martin Profile (Free Report)

Lockheed Martin Corporation (NYSE: LMT) is a global aerospace and defense company that designs, develops and manufactures advanced technology systems for government and commercial customers. Formed through the 1995 merger of Lockheed Corporation and Martin Marietta, the company is headquartered in Bethesda, Maryland, and focuses on providing integrated solutions across air, space, land and sea domains. Its primary customers include the U.S. Department of Defense, NASA and allied governments around the world.

Lockheed Martin’s product and service portfolio spans military aircraft, missile and fire-control systems, missile defense, space systems and satellite technologies, sensors and precision weapons.

Featured Articles Five stocks we like better than Lockheed Martin 3 Energy Stocks Raising Dividends as the Sector Surges 5 Reasons the S&P 500 Could Keep Rallying Through Year-End Walmart’s Post-Earnings Drop Could Be a Buying Opportunity The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future Want to see what other hedge funds are holding LMT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lockheed Martin Corporation (NYSE:LMT – Free Report).

Receive News & Ratings for Lockheed Martin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lockheed Martin and related companies with MarketBeat.com's FREE daily email newsletter.

Advisors Capital Management LLC bought a new position in shares of Stryker Corporation (NYSE:SYK – Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 89,485 shares of the medical technology company’s stock, valued at approximately $28,173,000.

Several other institutional investors also recently modified their holdings of the stock. Varma Mutual Pension Insurance Co boosted its stake in shares of Stryker by 10.5% in the 4th quarter. Varma Mutual Pension Insurance Co now owns 53,610 shares of the medical technology company’s stock valued at $18,842,000 after purchasing an additional 5,100 shares during the last quarter. QRG Capital Management Inc. raised its stake in Stryker by 7.4% during the fourth quarter. QRG Capital Management Inc. now owns 60,548 shares of the medical technology company’s stock worth $21,281,000 after buying an additional 4,186 shares during the last quarter. Swedbank AB raised its stake in Stryker by 6.6% during the fourth quarter. Swedbank AB now owns 129,027 shares of the medical technology company’s stock worth $45,349,000 after buying an additional 7,934 shares during the last quarter. Crossmark Global Holdings Inc. lifted its holdings in Stryker by 31.1% in the fourth quarter. Crossmark Global Holdings Inc. now owns 26,820 shares of the medical technology company’s stock valued at $9,426,000 after buying an additional 6,367 shares during the period. Finally, Royal Bank of Canada boosted its position in Stryker by 6.5% during the first quarter. Royal Bank of Canada now owns 3,273,232 shares of the medical technology company’s stock valued at $1,075,552,000 after acquiring an additional 199,863 shares during the last quarter. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth A number of equities research analysts have weighed in on SYK shares. Citizens Jmp lowered their target price on Stryker from $440.00 to $400.00 and set a “market outperform” rating for the company in a report on Monday, August 3rd. Needham & Company LLC reduced their price objective on shares of Stryker from $454.00 to $418.00 and set a “buy” rating for the company in a research report on Friday, May 1st. Deutsche Bank Aktiengesellschaft set a $315.00 price objective on shares of Stryker in a research note on Friday, May 1st. Wells Fargo & Company dropped their target price on shares of Stryker from $456.00 to $418.00 and set an “overweight” rating on the stock in a research report on Friday, May 1st. Finally, Canaccord Genuity Group reduced their price target on shares of Stryker from $435.00 to $400.00 and set a “buy” rating for the company in a report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $386.28.

Check Out Our Latest Analysis on SYK Stryker Price Performance Shares of SYK opened at $327.97 on Friday. The business’s fifty day moving average is $326.64 and its 200 day moving average is $332.66. Stryker Corporation has a 12-month low of $281.00 and a 12-month high of $396.86. The company has a quick ratio of 1.33, a current ratio of 2.16 and a debt-to-equity ratio of 0.59. The stock has a market cap of $125.80 billion, a P/E ratio of 33.99, a P/E/G ratio of 2.17 and a beta of 0.76.

Stryker (NYSE:SYK – Get Free Report) last announced its quarterly earnings results on Thursday, July 30th. The medical technology company reported $3.69 EPS for the quarter, beating analysts’ consensus estimates of $3.49 by $0.20. Stryker had a net margin of 14.43% and a return on equity of 23.63%. The business had revenue of $6.59 billion during the quarter, compared to analyst estimates of $6.58 billion. During the same quarter in the previous year, the business posted $3.13 EPS. Stryker’s quarterly revenue was up 9.4% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. Sell-side analysts anticipate that Stryker Corporation will post 15.02 earnings per share for the current fiscal year.

Stryker Announces Dividend The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be issued a $0.88 dividend. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Wednesday, September 30th. Stryker’s dividend payout ratio is currently 36.48%.

Insider Activity at Stryker In other Stryker news, Director Ronda E. Stryker sold 310,000 shares of Stryker stock in a transaction dated Tuesday, May 26th. The stock was sold at an average price of $312.23, for a total transaction of $96,791,300.00. Following the completion of the transaction, the director owned 1,924,880 shares in the company, valued at approximately $601,005,282.40. The trade was a 13.87% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Robert S. Fletcher sold 4,544 shares of the firm’s stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $306.87, for a total value of $1,394,417.28. Following the completion of the transaction, the vice president owned 10,582 shares in the company, valued at $3,247,298.34. This represents a 30.04% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 665,370 shares of company stock valued at $216,238,501. 4.60% of the stock is owned by corporate insiders.

Stryker Company Profile (Free Report)

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.

Read More Five stocks we like better than Stryker 3 Energy Stocks Raising Dividends as the Sector Surges 5 Reasons the S&P 500 Could Keep Rallying Through Year-End Walmart’s Post-Earnings Drop Could Be a Buying Opportunity The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK – Free Report).

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.

B. Metzler seel. Sohn & Co. AG purchased a new position in shares of Fastenal Company (NASDAQ:FAST – Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 689,676 shares of the company’s stock, valued at approximately $33,125,000. B. Metzler seel. Sohn & Co. AG owned 0.06% of Fastenal at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Mowery & Schoenfeld Wealth Management LLC acquired a new position in Fastenal during the second quarter worth $26,000. Evergreen Advisors LLC purchased a new position in Fastenal in the first quarter worth $26,000. Palladiem LLC acquired a new stake in Fastenal in the fourth quarter valued at $25,000. Elyxium Wealth LLC acquired a new stake in Fastenal in the fourth quarter valued at $25,000. Finally, MV Capital Management Inc. purchased a new stake in shares of Fastenal during the 4th quarter worth $29,000. 81.38% of the stock is currently owned by hedge funds and other institutional investors.

Fastenal Trading Down 1.5% NASDAQ:FAST opened at $50.66 on Friday. The company has a market capitalization of $58.13 billion, a PE ratio of 42.93, a price-to-earnings-growth ratio of 3.21 and a beta of 0.72. The company has a quick ratio of 2.21, a current ratio of 4.18 and a debt-to-equity ratio of 0.01. Fastenal Company has a 52-week low of $38.97 and a 52-week high of $52.92. The stock has a fifty day simple moving average of $47.86 and a 200-day simple moving average of $46.33.

Fastenal (NASDAQ:FAST – Get Free Report) last issued its quarterly earnings data on Tuesday, July 14th. The company reported $0.33 EPS for the quarter, meeting analysts’ consensus estimates of $0.33. Fastenal had a net margin of 15.45% and a return on equity of 34.03%. The firm had revenue of $2.39 billion for the quarter, compared to analysts’ expectations of $2.34 billion. During the same period in the prior year, the company earned $0.29 EPS. The firm’s revenue was up 14.7% on a year-over-year basis. On average, equities research analysts expect that Fastenal Company will post 1.26 earnings per share for the current fiscal year. Fastenal Increases Dividend The firm also recently declared a quarterly dividend, which will be paid on Tuesday, August 25th. Stockholders of record on Tuesday, July 28th will be given a $0.26 dividend. This is a boost from Fastenal’s previous quarterly dividend of $0.24. This represents a $1.04 annualized dividend and a dividend yield of 2.1%. The ex-dividend date is Tuesday, July 28th. Fastenal’s dividend payout ratio (DPR) is currently 88.14%.

Insider Activity at Fastenal In related news, Director Michael J. Ancius sold 3,000 shares of the company’s stock in a transaction that occurred on Tuesday, July 28th. The stock was sold at an average price of $49.00, for a total value of $147,000.00. Following the sale, the director owned 58,690 shares of the company’s stock, valued at approximately $2,875,810. This represents a 4.86% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Rita J. Heise sold 34,964 shares of the company’s stock in a transaction that occurred on Wednesday, August 5th. The shares were sold at an average price of $50.05, for a total value of $1,749,948.20. Following the completion of the sale, the director directly owned 20,000 shares in the company, valued at approximately $1,001,000. The trade was a 63.61% decrease in their position. The SEC filing for this sale provides additional information. 0.28% of the stock is owned by corporate insiders.

Analysts Set New Price Targets A number of equities analysts have recently weighed in on the stock. Barclays lowered their price target on shares of Fastenal from $47.00 to $46.00 and set an “equal weight” rating on the stock in a research note on Thursday, July 16th. Sanford C. Bernstein reiterated an “underperform” rating on shares of Fastenal in a research note on Wednesday, July 15th. Rothschild & Co Redburn set a $55.00 price objective on shares of Fastenal and gave the stock a “buy” rating in a report on Monday, July 13th. DA Davidson restated a “neutral” rating and set a $46.00 target price on shares of Fastenal in a research report on Wednesday, July 15th. Finally, Morgan Stanley increased their target price on shares of Fastenal from $48.00 to $52.00 and gave the company an “equal weight” rating in a report on Thursday, July 16th. Five research analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $49.17.

Get Our Latest Research Report on FAST

Fastenal Profile (Free Report)

Fastenal (NASDAQ: FAST) is a wholesale distributor of industrial and construction supplies, best known for its broad assortment of fasteners such as bolts, nuts, screws and anchors. Founded in Winona, Minnesota, Fastenal has grown from a regional supplier into a national and international distributor serving a wide range of end markets, including manufacturing, construction, maintenance, repair and operations (MRO), and government customers. The company is publicly traded and operates through a network of locally staffed branches combined with national distribution capabilities.

Product offerings extend beyond fasteners to include tools, safety and personal protective equipment, power transmission components, cutting and welding supplies, janitorial and material handling items, and other industrial consumables.

Read More Five stocks we like better than Fastenal 3 Energy Stocks Raising Dividends as the Sector Surges 5 Reasons the S&P 500 Could Keep Rallying Through Year-End Walmart’s Post-Earnings Drop Could Be a Buying Opportunity The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future Want to see what other hedge funds are holding FAST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Fastenal Company (NASDAQ:FAST – Free Report).

Receive News & Ratings for Fastenal Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fastenal and related companies with MarketBeat.com's FREE daily email newsletter.

Bowie Capital Management LLC purchased a new position in shares of Booking Holdings Inc. (NASDAQ:BKNG – Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 381,532 shares of the business services provider’s stock, valued at approximately $68,004,000. Booking comprises about 2.9% of Bowie Capital Management LLC’s portfolio, making the stock its 16th largest position. Bowie Capital Management LLC owned 0.05% of Booking as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in BKNG. Bogart Wealth LLC grew its stake in shares of Booking by 3,475.0% in the second quarter. Bogart Wealth LLC now owns 143 shares of the business services provider’s stock worth $25,000 after purchasing an additional 139 shares in the last quarter. Wilkerson Advisory Group LLC grew its stake in shares of Booking by 3,550.0% in the 2nd quarter. Wilkerson Advisory Group LLC now owns 146 shares of the business services provider’s stock worth $26,000 after purchasing an additional 142 shares during the last quarter. Camelot Portfolios LLC bought a new position in shares of Booking in the fourth quarter valued at $27,000. Osbon Capital Management LLC acquired a new stake in shares of Booking during the fourth quarter worth $27,000. Finally, First Financial Corp IN lifted its stake in Booking by 2,400.0% during the second quarter. First Financial Corp IN now owns 150 shares of the business services provider’s stock valued at $27,000 after buying an additional 144 shares in the last quarter. 92.42% of the stock is owned by institutional investors.

Booking Trading Down 1.5% Shares of Booking stock opened at $209.87 on Friday. Booking Holdings Inc. has a 1-year low of $150.14 and a 1-year high of $231.80. The firm has a fifty day simple moving average of $187.71 and a 200-day simple moving average of $177.15. The stock has a market capitalization of $157.69 billion, a price-to-earnings ratio of 23.23, a PEG ratio of 1.29 and a beta of 1.07.

Booking (NASDAQ:BKNG – Get Free Report) last issued its quarterly earnings results on Monday, August 3rd. The business services provider reported $2.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.43 by $0.11. The company had revenue of $7.35 billion for the quarter, compared to the consensus estimate of $7.19 billion. Booking had a negative return on equity of 102.96% and a net margin of 25.53%.The firm’s revenue was up 8.1% compared to the same quarter last year. During the same period last year, the business posted $55.40 earnings per share. As a group, research analysts predict that Booking Holdings Inc. will post 10.47 earnings per share for the current year. Booking Announces Dividend The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Friday, September 11th will be issued a dividend of $0.42 per share. The ex-dividend date is Friday, September 11th. This represents a $1.68 annualized dividend and a dividend yield of 0.8%. Booking’s payout ratio is presently 18.58%.

Wall Street Analysts Forecast Growth A number of research firms have recently issued reports on BKNG. Mizuho set a $240.00 target price on Booking in a report on Wednesday, August 5th. Argus increased their price objective on Booking from $210.00 to $245.00 and gave the stock a “buy” rating in a research note on Monday, August 10th. UBS Group raised their price objective on Booking from $266.00 to $274.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. Cantor Fitzgerald lifted their target price on Booking from $175.00 to $220.00 and gave the company a “neutral” rating in a research note on Wednesday, August 5th. Finally, Gordon Haskett upped their price objective on shares of Booking from $217.00 to $220.00 and gave the company a “buy” rating in a research note on Thursday, April 30th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-seven have issued a Buy rating and eight have given a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $235.72.

Read Our Latest Report on BKNG

Insider Transactions at Booking In other Booking news, VP Peter J. Millones sold 62,500 shares of the company’s stock in a transaction that occurred on Tuesday, May 26th. The stock was sold at an average price of $163.67, for a total value of $10,229,375.00. Following the completion of the transaction, the vice president owned 425,075 shares of the company’s stock, valued at $69,572,025.25. This represents a 12.82% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Ewout L. Steenbergen sold 20,000 shares of the company’s stock in a transaction on Wednesday, August 12th. The shares were sold at an average price of $211.03, for a total value of $4,220,600.00. Following the completion of the transaction, the chief financial officer owned 59,794 shares of the company’s stock, valued at $12,618,327.82. The trade was a 25.06% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 140,050 shares of company stock valued at $26,341,680. 0.17% of the stock is currently owned by insiders.

Booking Profile (Free Report)

Booking Holdings Inc is a global online travel company that operates a portfolio of consumer brands and technology platforms that facilitate the search for and booking of travel services. The company’s businesses focus on accommodations, transportation and related travel services through consumer-facing websites and apps as well as partner distribution channels. Booking Holdings was originally founded as Priceline in the late 1990s and adopted the Booking Holdings name in 2018; it is headquartered in Norwalk, Connecticut.

Its core offerings include online reservations for hotels, vacation rentals and other lodging; flight and car rental search and booking; and ancillary services that support travel planning and on-property experiences.

Featured Articles Five stocks we like better than Booking 3 Energy Stocks Raising Dividends as the Sector Surges 5 Reasons the S&P 500 Could Keep Rallying Through Year-End Walmart’s Post-Earnings Drop Could Be a Buying Opportunity The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future

Receive News & Ratings for Booking Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Booking and related companies with MarketBeat.com's FREE daily email newsletter.

Advisors Preferred LLC bought a new stake in Freeport-McMoRan Inc. (NYSE:FCX – Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 28,136 shares of the natural resource company’s stock, valued at approximately $1,715,000.

Several other large investors also recently bought and sold shares of the business. Strategic Investment Solutions Inc. IL purchased a new position in Freeport-McMoRan in the fourth quarter worth about $25,000. Steph & Co. raised its position in Freeport-McMoRan by 43.7% during the first quarter. Steph & Co. now owns 493 shares of the natural resource company’s stock valued at $29,000 after purchasing an additional 150 shares during the period. Cassaday & Co Wealth Management LLC bought a new stake in shares of Freeport-McMoRan in the 1st quarter valued at approximately $29,000. Kemnay Advisory Services Inc. bought a new stake in shares of Freeport-McMoRan in the 4th quarter valued at approximately $29,000. Finally, SHP Wealth Management purchased a new position in shares of Freeport-McMoRan in the 4th quarter worth approximately $30,000. Institutional investors own 80.77% of the company’s stock.

Freeport-McMoRan Price Performance Shares of FCX stock opened at $71.18 on Friday. Freeport-McMoRan Inc. has a twelve month low of $35.15 and a twelve month high of $72.28. The stock has a market capitalization of $102.22 billion, a price-to-earnings ratio of 35.06, a P/E/G ratio of 0.69 and a beta of 1.37. The stock has a fifty day simple moving average of $64.38 and a two-hundred day simple moving average of $63.33. The company has a current ratio of 2.07, a quick ratio of 0.92 and a debt-to-equity ratio of 0.25.

Freeport-McMoRan (NYSE:FCX – Get Free Report) last announced its quarterly earnings results on Thursday, July 23rd. The natural resource company reported $0.74 EPS for the quarter, beating the consensus estimate of $0.62 by $0.12. The firm had revenue of $7.03 billion for the quarter, compared to analyst estimates of $6.62 billion. Freeport-McMoRan had a return on equity of 10.63% and a net margin of 11.39%.The business’s revenue for the quarter was down 7.3% on a year-over-year basis. During the same quarter last year, the firm posted $0.54 earnings per share. On average, analysts predict that Freeport-McMoRan Inc. will post 2.79 EPS for the current fiscal year. Freeport-McMoRan Announces Dividend The firm also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Wednesday, July 15th were given a dividend of $0.075 per share. The ex-dividend date of this dividend was Wednesday, July 15th. This represents a $0.30 dividend on an annualized basis and a yield of 0.4%. Freeport-McMoRan’s dividend payout ratio (DPR) is 14.78%.

Analysts Set New Price Targets Several equities research analysts have recently weighed in on the stock. BNP Paribas Exane increased their target price on shares of Freeport-McMoRan from $71.00 to $82.00 and gave the company an “outperform” rating in a research note on Thursday, June 18th. Bank of America lifted their price target on shares of Freeport-McMoRan from $74.00 to $80.00 and gave the stock a “buy” rating in a research note on Thursday, July 9th. Scotiabank upped their price target on shares of Freeport-McMoRan from $67.00 to $77.00 and gave the company a “sector outperform” rating in a report on Monday, June 15th. CICC Research reduced their price objective on shares of Freeport-McMoRan from $64.40 to $63.40 and set an “outperform” rating on the stock in a research report on Tuesday, April 28th. Finally, Wells Fargo & Company raised their price objective on shares of Freeport-McMoRan from $68.00 to $70.00 and gave the stock an “overweight” rating in a research note on Friday, July 24th. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $70.27.

View Our Latest Stock Analysis on FCX

Insider Transactions at Freeport-McMoRan In other news, CAO Stephen T. Higgins sold 14,277 shares of the company’s stock in a transaction that occurred on Wednesday, August 5th. The shares were sold at an average price of $69.50, for a total value of $992,251.50. Following the completion of the sale, the chief accounting officer owned 54,618 shares of the company’s stock, valued at approximately $3,795,951. This represents a 20.72% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Ellie L. Mikes sold 4,773 shares of the stock in a transaction that occurred on Wednesday, August 5th. The shares were sold at an average price of $70.00, for a total transaction of $334,110.00. Following the transaction, the chief accounting officer owned 36,000 shares in the company, valued at approximately $2,520,000. This represents a 11.71% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 26,600 shares of company stock worth $1,802,012 in the last three months. Insiders own 0.73% of the company’s stock.

(Free Report)

Freeport-McMoRan Inc is a U.S.-based natural resources company primarily engaged in the exploration, mining and processing of copper, gold and molybdenum. Its operations encompass large-scale open-pit and underground mining as well as associated concentrator and milling facilities. The company produces copper in the form of concentrates and cathodes, and also recovers gold and molybdenum as co-products; its business model includes exploration, development, mining, beneficiation and the sale of bulk commodities to smelters and industrial customers.

Freeport-McMoRan conducts operations and development activities across multiple geographies, with substantial assets in the Americas and Indonesia.

Featured Articles Five stocks we like better than Freeport-McMoRan 3 Energy Stocks Raising Dividends as the Sector Surges 5 Reasons the S&P 500 Could Keep Rallying Through Year-End Walmart’s Post-Earnings Drop Could Be a Buying Opportunity The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future

Receive News & Ratings for Freeport-McMoRan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Freeport-McMoRan and related companies with MarketBeat.com's FREE daily email newsletter.

Advisors Capital Management LLC bought a new position in shares of The Sherwin-Williams Company (NYSE:SHW – Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 14,614 shares of the specialty chemicals company’s stock, valued at approximately $5,032,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its stake in shares of Sherwin-Williams by 2.7% during the 4th quarter. Vanguard Group Inc. now owns 23,237,824 shares of the specialty chemicals company’s stock valued at $7,529,752,000 after buying an additional 600,119 shares during the period. BlackRock Inc. acquired a new position in Sherwin-Williams in the second quarter valued at $6,100,083,000. State Street Corp boosted its holdings in Sherwin-Williams by 2.4% in the fourth quarter. State Street Corp now owns 15,638,974 shares of the specialty chemicals company’s stock valued at $5,067,497,000 after acquiring an additional 364,832 shares during the last quarter. Geode Capital Management LLC grew its position in Sherwin-Williams by 0.7% during the fourth quarter. Geode Capital Management LLC now owns 5,231,615 shares of the specialty chemicals company’s stock valued at $1,687,498,000 after acquiring an additional 37,145 shares during the period. Finally, Norges Bank purchased a new stake in Sherwin-Williams during the fourth quarter valued at about $1,089,450,000. 77.67% of the stock is owned by institutional investors and hedge funds.

Sherwin-Williams Price Performance
SHW opened at $346.60 on Friday. The Sherwin-Williams Company has a twelve month low of $289.86 and a twelve month high of $379.65. The firm has a market cap of $84.14 billion, a price-to-earnings ratio of 31.94, a PEG ratio of 2.63 and a beta of 1.10. The company has a current ratio of 0.73, a quick ratio of 0.46 and a debt-to-equity ratio of 2.16. The company has a fifty day simple moving average of $339.56 and a 200 day simple moving average of $332.71.

Sherwin-Williams (NYSE:SHW – Get Free Report) last issued its quarterly earnings data on Tuesday, July 28th. The specialty chemicals company reported $3.70 EPS for the quarter, topping analysts’ consensus estimates of $3.52 by $0.18. The firm had revenue of $6.79 billion for the quarter, compared to analyst estimates of $6.60 billion. Sherwin-Williams had a net margin of 11.01% and a return on equity of 67.97%. The firm’s revenue was up 7.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $3.38 EPS. Sherwin-Williams has set its FY 2026 guidance at 11.800-12.200 EPS. Equities research analysts expect that The Sherwin-Williams Company will post 12.08 EPS for the current fiscal year.
Sherwin-Williams Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Friday, August 21st will be paid a $0.80 dividend. The ex-dividend date is Friday, August 21st. This represents a $3.20 annualized dividend and a dividend yield of 0.9%. Sherwin-Williams’s payout ratio is 29.49%.

Insider Transactions at Sherwin-Williams
In other news, insider Karl J. Jorgenrud sold 7,886 shares of the firm’s stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $368.30, for a total transaction of $2,904,413.80. Following the completion of the sale, the insider owned 11,944 shares of the company’s stock, valued at approximately $4,398,975.20. This trade represents a 39.77% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Justin T. Binns sold 13,500 shares of Sherwin-Williams stock in a transaction on Monday, August 17th. The stock was sold at an average price of $352.70, for a total transaction of $4,761,450.00. Following the completion of the sale, the insider owned 21,937 shares of the company’s stock, valued at approximately $7,737,179.90. This trade represents a 38.10% decrease in their position. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.23% of the company’s stock.

Analyst Ratings Changes
A number of equities analysts have recently commented on SHW shares. Morgan Stanley restated an “overweight” rating and issued a $395.00 price objective (up from $385.00) on shares of Sherwin-Williams in a report on Wednesday, July 29th. BMO Capital Markets reissued an “outperform” rating and set a $405.00 target price (up from $400.00) on shares of Sherwin-Williams in a research report on Wednesday, July 29th. Weiss Ratings upgraded shares of Sherwin-Williams from a “hold (c)” rating to a “hold (c+)” rating in a report on Friday, July 31st. Berenberg Bank set a $380.00 price target on shares of Sherwin-Williams in a research report on Monday, June 8th. Finally, Evercore reiterated an “outperform” rating on shares of Sherwin-Williams in a research note on Friday, May 8th. Nine equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $385.44.

View Our Latest Analysis on Sherwin-Williams

Sherwin-Williams Profile
(Free Report)

Sherwin-Williams (NYSE: SHW) is a global manufacturer and distributor of paints, coatings and related products. Founded in 1866 and headquartered in Cleveland, Ohio, the company supplies a broad range of coatings for residential, commercial and industrial applications. Its product offering includes architectural paints and stains, industrial and protective coatings, automotive finishes, and a variety of sundry products such as primers, sealants and specialty treatments used by professionals and consumers.

The company sells through multiple channels, including a large network of company-operated retail paint stores that serve professional contractors and do-it-yourself consumers, as well as through distributors and mass retailers.

Read More

Five stocks we like better than Sherwin-Williams
3 Energy Stocks Raising Dividends as the Sector Surges
5 Reasons the S&P 500 Could Keep Rallying Through Year-End
Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future

Receive News & Ratings for Sherwin-Williams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sherwin-Williams and related companies with MarketBeat.com's FREE daily email newsletter.

Advisors Capital Management LLC decreased its position in shares of SLB Limited (NYSE:SLB – Free Report) by 17.4% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 108,453 shares of the oil and gas company’s stock after selling 22,787 shares during the quarter. Advisors Capital Management LLC’s holdings in SLB were worth $5,042,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in SLB. Evergreen Advisors LLC bought a new stake in SLB in the 1st quarter worth about $26,000. MV Capital Management Inc. purchased a new stake in shares of SLB during the 4th quarter valued at about $28,000. Strategic Wealth Advisors LLC purchased a new stake in shares of SLB during the 4th quarter valued at about $30,000. Costello Asset Management INC grew its stake in shares of SLB by 93.3% in the first quarter. Costello Asset Management INC now owns 580 shares of the oil and gas company’s stock worth $30,000 after acquiring an additional 280 shares during the period. Finally, Lloyd Advisory Services LLC. purchased a new position in shares of SLB during the fourth quarter valued at approximately $31,000. Institutional investors own 81.99% of the company’s stock.

SLB Stock Up 0.3% NYSE SLB opened at $53.71 on Friday. SLB Limited has a 52 week low of $31.64 and a 52 week high of $58.82. The company has a quick ratio of 1.05, a current ratio of 1.44 and a debt-to-equity ratio of 0.41. The company has a market capitalization of $79.71 billion, a P/E ratio of 25.95, a price-to-earnings-growth ratio of 3.53 and a beta of 0.73. The stock’s 50-day moving average price is $49.34 and its 200-day moving average price is $51.22.

SLB (NYSE:SLB – Get Free Report) last announced its quarterly earnings data on Saturday, July 25th. The oil and gas company reported $0.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.51 by $0.04. The firm had revenue of $8.97 billion during the quarter, compared to analysts’ expectations of $8.67 billion. SLB had a net margin of 8.53% and a return on equity of 14.05%. During the same period in the prior year, the company posted $0.74 earnings per share. The company’s revenue for the quarter was up 5.0% compared to the same quarter last year. On average, equities research analysts predict that SLB Limited will post 2.5 earnings per share for the current year. SLB Dividend Announcement The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 8th. Investors of record on Wednesday, September 2nd will be issued a $0.295 dividend. The ex-dividend date of this dividend is Wednesday, September 2nd. This represents a $1.18 dividend on an annualized basis and a yield of 2.2%. SLB’s payout ratio is currently 57.00%.

SLB News Roundup Here are the key news stories impacting SLB this week:

Positive Sentiment: Venezuela expansion could add meaningful work. SLB is preparing to restart as many as 15 oil rigs in Venezuela and is working with Formentera Partners to reactivate existing equipment or bring in additional rigs. Venezuela also signed agreements with SLB and other companies aimed at increasing oil production, potentially creating new drilling and well-services revenue. SLB Prepares to Restart 15 Oil Rigs in Venezuela SLB, Formentera working to activate drilling rigs in Venezuela Venezuela Signs Deals With SLB and Hunt Positive Sentiment: New offshore work in Brunei adds backlog visibility. Shell selected SLB for a production-restoration project offshore Brunei, providing another international contract and reinforcing demand for SLB’s technical services. Shell Taps SLB for Production Restarts offshore Brunei Positive Sentiment: Industry spending trends remain supportive. Commentary on rising upstream capital spending and SLB’s EnerCom presentation highlights the potential for increased customer activity, particularly in international and offshore markets. This supports the company’s longer-term revenue outlook. What Could Rising Upstream Spending Mean for SLB SLB Presents at the EnerCom Energy Investment Conference Neutral Sentiment: Risks temper the bullish impact. Venezuela projects may face sanctions, operational, payment and political risks, while higher long-term Treasury yields could pressure income-oriented stocks and raise financing costs across the energy sector. Dividend Stocks and Rising Treasury Yields Analyst Ratings Changes A number of research firms recently commented on SLB. Evercore reiterated an “outperform” rating and set a $66.00 price objective on shares of SLB in a research report on Monday, July 27th. BMO Capital Markets raised their target price on SLB from $59.00 to $63.00 and gave the stock an “outperform” rating in a research report on Monday, July 27th. JPMorgan Chase & Co. boosted their price target on SLB from $54.00 to $61.00 and gave the company an “overweight” rating in a research note on Monday, April 27th. Piper Sandler upped their price target on shares of SLB from $59.00 to $64.00 and gave the company an “overweight” rating in a research report on Monday, July 27th. Finally, Citigroup lowered their price objective on shares of SLB from $68.00 to $63.00 and set a “buy” rating on the stock in a research note on Wednesday, July 1st. Two research analysts have rated the stock with a Strong Buy rating, eighteen have given a Buy rating, one has given a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $61.35.

Get Our Latest Stock Report on SLB

SLB Profile (Free Report)

SLB (NYSE: SLB), historically known as Schlumberger, is a leading global provider of technology, integrated project management and information solutions for the energy industry. Founded by Conrad and Marcel Schlumberger in 1926, the company develops and supplies products and services used across the exploration, drilling, completion and production phases of oil and gas development. Its offerings are intended to help operators characterize reservoirs, drill and complete wells, optimize production and manage field operations throughout the asset lifecycle.

SLB’s product and service portfolio spans reservoir characterization and well testing, wireline and logging services, directional drilling and drilling tools, well construction and completion technologies, production systems, and subsea equipment.

Read More Five stocks we like better than SLB 3 Energy Stocks Raising Dividends as the Sector Surges 5 Reasons the S&P 500 Could Keep Rallying Through Year-End Walmart’s Post-Earnings Drop Could Be a Buying Opportunity The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future Want to see what other hedge funds are holding SLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SLB Limited (NYSE:SLB – Free Report).

Receive News & Ratings for SLB Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SLB and related companies with MarketBeat.com's FREE daily email newsletter.

BEIJING, Aug. 21, 2026 (GLOBE NEWSWIRE) -- KE Holdings Inc. (“Beike” or the “Company”) (NYSE: BEKE; HKEX: 2423), a leading integrated online and offline platform for housing transactions and services, today announced its unaudited financial results for the second quarter ended June 30, 2026.

Business and Financial Highlights for the Second Quarter 2026

Gross transaction value (GTV)1 was RMB933.8 billion (US$137.6 billion), an increase of 6.3% year-over-year. GTV of existing home transactions was RMB629.9 billion (US$92.8 billion), an increase of 8.0% year-over-year. GTV of new home transactions was RMB258.4 billion (US$38.1 billion), an increase of 1.2% year-over-year.Net revenues were RMB24.5 billion (US$3.6 billion), a decrease of 5.7% year-over-year.Net income was RMB2,624 million (US$387 million), an increase of 100.8% year-over-year. Adjusted net income2 was RMB3,185 million (US$469 million), an increase of 74.9% year-over-year.Number of stores was 60,274 as of June 30, 2026, a 0.4% decrease from one year ago. Number of active stores3 was 57,803 as of June 30, 2026, a 1.5% decrease from one year ago.Number of agents was 540,634 as of June 30, 2026, a 3.1% decrease from one year ago. Number of active agents4 was 454,571 as of June 30, 2026, a 7.5% decrease from one year ago.Mobile monthly active users (MAU)5 averaged 45.7 million in the second quarter of 2026, compared to 48.7 million in the same period of 2025. Mr. Stanley Yongdong Peng, Chairman of the Board and Chief Executive Officer of Beike, commented, “In the second quarter of 2026, we saw our operating foundation strengthen further, while our organizational transformation began to take deeper root in day-to-day operations. Starting with consumer needs and practical challenges encountered on the front lines, we are further enhancing collaboration among professional service providers, our platform and AI: professional service providers exercise judgment and take accountability; our platform facilitates collaboration and safeguards service delivery; and AI enables professional expertise to be codified into verifiable and reusable organizational capabilities.

Looking ahead, we will remain committed to pursuing quality growth at scale and continue to assess the effectiveness of our transformation across consumer experience, professional service provider development, operating efficiency, unit economics, and replicability across cities and service scenarios, laying a stronger foundation for the Company’s long-term, sustainable growth.”

Mr. Tao Xu, Executive Director and Chief Financial Officer of Beike, added, “In the second quarter, the proactive adjustments we made earlier to our cost structure yielded further results, enabling our resource allocation to better align with the current market environment. Building on this foundation, we continued to enhance operating efficiency with a focus on customer value. The scale of our housing transaction services recovered, while the Company’s profitability further improved. The contribution margins of all our major business lines increased both year-over-year and quarter-over-quarter, driving our gross margin up by 6.7 percentage points year-over-year to 28.6%. Meanwhile, operating expenses decreased by 14.1% year-over-year. Adjusted operating margin and adjusted net income margin reached 14.6% and 13.0%, respectively, both marking their highest levels in three years.

In the second quarter, the Company repurchased approximately US$250 million of its shares and conducted share repurchases in Hong Kong for the first time. Looking ahead, building on our more efficient cost structure, we will further direct resources toward building capabilities that can create greater value for customers, continue to strengthen our operating resilience, and drive long-term sustainable growth.”

Second Quarter 2026 Financial Results

Net Revenues

Net revenues decreased by 5.7% to RMB24.5 billion (US$3.6 billion) in the second quarter of 2026 from RMB26.0 billion in the same period of 2025, primarily attributable to decreased net revenues from home renovation and furnishing and home rental services, which was partially offset by the increase of net revenues from new home and existing home transaction services driven by improved productivity per connected store.

Net revenues from existing home transaction services increased by 4.5% to RMB7.0 billion (US$1.0 billion) in the second quarter of 2026 from RMB6.7 billion in the same period of 2025, primarily due to an 8.0% increase in GTV of existing home transactions to RMB629.9 billion (US$92.8 billion) in the second quarter of 2026 from RMB583.5 billion in the same period of 2025.Among that, (i) commission revenue decreased by 1.4% to RMB5.3 billion (US$0.8 billion) in the second quarter of 2026 from RMB5.4 billion in the same period of 2025, primarily due to a 3.1% decrease in GTV of existing home transactions served by Lianjia stores to RMB206.6 billion (US$30.4 billion) in the second quarter of 2026 from RMB213.1 billion in the same period of 2025; and

(ii) revenues derived from platform service, franchise service and other value-added services, which are mostly charged to connected stores and agents on the Company’s platform, increased by 27.8% to RMB1.7 billion (US$0.3 billion) in the second quarter of 2026 from RMB1.4 billion in the same period of 2025, primarily due to a 14.3% increase in the GTV of existing home transactions served by connected agents on the Company’s platform to RMB423.3 billion (US$62.4 billion) in the second quarter of 2026 from RMB370.4 billion in the same period of 2025 driven by improved productivity per connected store and the increased revenues from certain value-added services that were less directly linked to GTV.

Net revenues from new home transaction services increased by 3.8% to RMB8.9 billion (US$1.3 billion) in the second quarter of 2026 from RMB8.6 billion in the same period of 2025, primarily due to deeper coverage of high-quality projects, which contributed to a 1.2% increase of GTV of new home transactions to RMB258.4 billion (US$38.1 billion) in the second quarter of 2026 from RMB255.4 billion in the same period of 2025. Of these, the GTV of new home transactions facilitated on Beike platform through connected agents, dedicated sales team with the expertise in new home transaction services and other sales channels increased by 0.9% to RMB210.2 billion (US$31.0 billion) in the second quarter of 2026 from RMB208.2 billion in the same period of 2025, while the GTV of new home transactions served by Lianjia brand increased by 2.3% to RMB48.2 billion (US$7.1 billion) in the second quarter of 2026 from RMB47.1 billion in the same period of 2025.Net revenues from home renovation and furnishing decreased by 30.1% to RMB3.2 billion (US$0.5 billion) in the second quarter of 2026 from RMB4.6 billion in the same period of 2025, as the Company proactively optimized its customer acquisition channel mix and moderated the pace of certain non-brokerage channels.Net revenues from home rental services decreased by 14.8% to RMB4.8 billion (US$0.7 billion) in the second quarter of 2026 from RMB5.7 billion in the same period of 2025, primarily due to the impact of an increasing proportion of new product offering within the Carefree Rent business. Under the new model, revenue is recognized based on net service fees derived from two sources: (1) commissions earned for facilitating the signing of lease agreements between homeowners and tenants; and (2) fees for lease term management services rendered throughout the lease period. The decrease was partially offset by the increase in the number of rental units under the Carefree Rent business.Net revenues from emerging and other services increased by 26.4% to RMB546 million (US$80 million) in the second quarter of 2026 from RMB432 million in the same period of 2025, primarily due to the increase of revenues from financial services. Contribution Margin

The Company also reviews contribution margin to measure segment profitability. The Company defines contribution for each service line as the revenue less the direct compensation to its internal agents and sales professionals, split commission to connected agents and other sales channels for such services, property leasing costs and direct operating costs related to home rental services and direct costs for home renovation and furnishing. The Company defines contribution margin as a percentage of contribution bearing to revenue.

Contribution margin for existing home transaction services. The contribution margin for existing home transaction services increased to 46.1% in the second quarter of 2026 from 39.9% in the same period of 2025, primarily attributable to a lower fixed compensation costs for Lianjia agents as a percentage of net revenues from existing home transaction services, and a higher proportion of revenues derived from platform service, franchise service and other value-added services with a higher margin than commission revenues.Contribution margin for new home transaction services. The contribution margin for new home transaction services increased to 28.8% in the second quarter of 2026 from 24.4% in the same period of 2025, primarily attributable to cost structure optimization driven by refined operations.Contribution margin for home renovation and furnishing. The contribution margin for home renovation and furnishing increased to 39.6% in the second quarter of 2026 from 32.1% in the same period of 2025, primarily attributable to enhanced supply chain capabilities, which helped reduce material costs.Contribution margin for home rental services. The contribution margin for home rentals increased to 15.3% in the second quarter of 2026 from 8.4% in the same period of 2025, primarily driven by the continuous increase in the proportion of high-margin new service offerings with revenues recognized under the net service fee method under the Carefree Rent business. In addition, improved operational efficiency further supported healthier profitability. Cost of Revenues

Total cost of revenues decreased by 13.7% to RMB17.5 billion (US$2.6 billion) in the second quarter of 2026 from RMB20.3 billion in the same period of 2025.

Commission – split. The Company’s cost of revenues for commissions to connected agents and other sales channels decreased by 2.3% to RMB5.8 billion (US$0.9 billion) in the second quarter of 2026 from RMB5.9 billion in the same period of 2025, primarily due to cost structure optimization driven by refined operations of new home transaction services with relatively flat year-over-year GTV of new home transactions facilitated on Beike platform through connected agents, dedicated sales team with the expertise in new home transaction services and other sales channels.Commission and compensation – internal. The Company’s cost of revenues for internal commission and compensation decreased by 4.8% to RMB4.5 billion (US$0.7 billion) in the second quarter of 2026 from RMB4.7 billion in the same period of 2025, primarily attributable to decreased fixed personnel costs.Cost of home renovation and furnishing. The Company’s cost of revenues for home renovation and furnishing was RMB1.9 billion (US$0.3 billion) in the second quarter of 2026, a decrease of 37.8% from RMB3.1 billion in the same period of 2025, primarily due to lower net revenues from home renovation and furnishing and increased contribution margin. Cost of home rental services. The Company’s cost of revenues for home rental services, which mainly consists of variable cost, decreased by 21.3% to RMB4.1 billion (US$0.6 billion) in the second quarter of 2026 from RMB5.2 billion in the same period of 2025, primarily due to the growing portion of offerings that recognize revenue under the net service fee method and contribute higher profit margins, as well as operational efficiency improvements.Cost related to stores. The Company’s cost related to stores decreased by 25.9% to RMB564 million (US$83 million) in the second quarter of 2026 from RMB762 million in the same period of 2025, primarily attributable to Lianjia store optimization.Other costs. The Company’s other costs increased by 8.7% to RMB640 million (US$94 million) in the second quarter of 2026 from RMB588 million in the same period of 2025, primarily attributable to increased share-based compensation costs. Gross Profit

Gross profit increased by 23.1% to RMB7.0 billion (US$1.0 billion) in the second quarter of 2026 from RMB5.7 billion in the same period of 2025. Gross margin increased to 28.6% in the second quarter of 2026 from 21.9% in the same period of 2025, primarily due to higher contribution margins for all main segments.

Income from Operations

Total operating expenses decreased by 14.1% to RMB4.0 billion (US$0.6 billion) in the second quarter of 2026 from RMB4.6 billion in the same period of 2025, primarily due to the Company’s previous cost optimization initiatives.

General and administrative expenses decreased by 2.1% to RMB2.0 billion (US$0.3 billion) in the second quarter of 2026 from RMB2.1 billion in the same period of 2025, primarily due to decreased personnel costs and overheads as a result of a decrease in headcount, partially offset by the mainly non-recurring provision for credit losses.Sales and marketing expenses decreased by 26.1% to RMB1.4 billion (US$0.2 billion) in the second quarter of 2026 from RMB1.9 billion in the same period of 2025, primarily due to lower personnel costs and reduced advertising and promotion expenses, as well as the decreased scale-driven variable selling expenses of home renovation and furnishing.Research and development expenses decreased by 13.4% to RMB549 million (US$81 million) in the second quarter of 2026 from RMB633 million in the same period of 2025, primarily due to decreased personnel costs as a result of a decrease in headcount of research and development personnel and decreased technical service fees. Income from operations was RMB3,026 million (US$446 million) in the second quarter of 2026, compared to income from operations of RMB1,059 million in the same period of 2025. Operating margin increased to 12.3% in the second quarter of 2026 from 4.1% in the same period of 2025, primarily due to increased gross profit margin and improved operating leverage.

Adjusted income from operations6 was RMB3,592 million (US$529 million) in the second quarter of 2026, compared to RMB1,607 million in the same period of 2025. Adjusted operating margin7 was 14.6% in the second quarter of 2026, compared to 6.2% in the same period of 2025. Adjusted EBITDA8 was RMB4,175 million (US$615 million) in the second quarter of 2026, compared to RMB2,203 million in the same period of 2025.

Net Income

Net income increased by 100.8% to RMB2,624 million (US$387 million) in the second quarter of 2026 from RMB1,307 million in the same period of 2025.

Adjusted net income increased by 74.9% to RMB3,185 million (US$469 million) in the second quarter of 2026, from RMB1,821 million in the same period of 2025.

Net Income attributable to KE Holdings Inc.’s Ordinary Shareholders

Net income attributable to KE Holdings Inc.’s ordinary shareholders was RMB2,623 million (US$387 million) in the second quarter of 2026, compared to RMB1,301 million in the same period of 2025.

Adjusted net income attributable to KE Holdings Inc.’s ordinary shareholders9 was RMB3,184 million (US$469 million) in the second quarter of 2026, compared to RMB1,815 million in the same period of 2025.

Net Income per ADS

Basic and diluted net income per ADS attributable to KE Holdings Inc.’s ordinary shareholders10 were RMB2.43 (US$0.36) and RMB2.35 (US$0.35) in the second quarter of 2026, respectively, compared to basic and diluted net income per ADS attributable to KE Holdings Inc.’s ordinary shareholders of RMB1.16 and RMB1.11 in the same period of 2025, respectively.

Adjusted basic and diluted net income per ADS attributable to KE Holdings Inc.’s ordinary shareholders11 were RMB2.95 (US$0.43) and RMB2.85 (US$0.42) in the second quarter of 2026, respectively, compared to RMB1.62 and RMB1.55 in the same period of 2025, respectively.

Cash, Cash Equivalents, Restricted Cash and Short-Term Investments

                As of June 30, 2026, the combined balance of the Company’s cash, cash equivalents, restricted cash and short-term investments amounted to RMB56.0 billion (US$8.3 billion).

Share Repurchase Program

As previously disclosed, the Company established a share repurchase program in August 2022 and upsized and extended it in August 2023, August 2024 and August 2025, under which the Company may repurchase up to US$5 billion worth of its Class A ordinary shares and/or ADSs until August 31, 2028, subject to obtaining a general unconditional mandate for the repurchase from the shareholders of the Company at each of the next two annual general meetings to be held in the forthcoming years to continue its share repurchase after the expiry of the existing share repurchase mandate granted by the annual general meeting held on June 12, 2026. As of June 30, 2026, the Company had purchased, in aggregate, approximately 185.4 million ADSs (representing approximately 556.3 million Class A ordinary shares) on the New York Stock Exchange for a consideration of approximately US$2,967.7 million, as well as approximately 4.9 million Class A ordinary shares on the Hong Kong Stock Exchange for a consideration of approximately HK$201.5 million under this share repurchase program since its launch.

Conference Call Information

The Company will hold an earnings conference call at 8:00 A.M. U.S. Eastern Time on Friday, August 21, 2026 (8:00 P.M. Beijing/Hong Kong Time on Friday, August 21, 2026) to discuss the financial results.

For participants who wish to join the conference call using dial-in numbers, please complete online registration using the link provided below at least 20 minutes prior to the scheduled call start time. Dial-in numbers, passcode and unique access PIN would be provided upon registering.

Participant Online Registration:

Chinese Line: https://s1.c-conf.com/diamondpass/10055963-m4ns1a.html

English Simultaneous Interpretation Line (listen-only mode): https://s1.c-conf.com/diamondpass/10055964-md34ad.html

A replay of the conference call will be accessible through August 28, 2026, by dialing the following numbers:

United States:+1-855-883-1031Mainland, China:400-1209-216Hong Kong, China:800-930-639International:+61-7-3107-6325Replay PIN (Chinese line):10055963Replay PIN (English simultaneous interpretation line):10055964   A live and archived webcast of the conference call will also be available at the Company’s investor relations website at https://investors.ke.com.

Exchange Rate

This press release contains translations of certain RMB amounts into U.S. dollars (“US$”) at specified rates solely for the convenience of the reader. Unless otherwise stated, all translations from RMB to US$ were made at the rate of RMB6.7851 to US$1.00, the noon buying rate in effect on June 30, 2026, in the H.10 statistical release of the Federal Reserve Board. The Company makes no representation that the RMB or US$ amounts referred could be converted into US$ or RMB, as the case may be, at any particular rate or at all. For analytical presentation, all percentages are calculated using the numbers presented in the financial information contained in this earnings release.

Non-GAAP Financial Measures

The Company uses adjusted income (loss) from operations, adjusted net income (loss), adjusted net income (loss) attributable to KE Holdings Inc.’s ordinary shareholders, adjusted operating margin, adjusted EBITDA and adjusted net income (loss) per ADS attributable to KE Holdings Inc.’s ordinary shareholders, each a non-GAAP financial measure, in evaluating its operating results and formulating its business plan. Beike believes that these non-GAAP financial measures help identify underlying trends in the Company’s business that could otherwise be distorted by the effect of certain expenses that the Company includes in its net income (loss). Beike also believes that these non-GAAP financial measures provide useful information about its results of operations, enhance the overall understanding of its past performance and future prospects and allow for greater visibility with respect to key metrics used by its management in formulating its business plan. A limitation of using these non-GAAP financial measures is that these non-GAAP financial measures exclude share-based compensation expenses that have been, and will continue to be for the foreseeable future, a significant recurring expense in the Company’s business. The Group recognized fair value loss and impairment in relation to its investments in Beihaojia business. As such impairment does not represent a non-recurring item, it has not been excluded when calculating Non‑GAAP financial measures.

The presentation of these non-GAAP financial measures should not be considered in isolation or construed as an alternative to gross profit, net income (loss) or any other measure of performance or as an indicator of its operating performance. Investors are encouraged to review these non-GAAP financial measures and the reconciliation to the most directly comparable GAAP measures. The non-GAAP financial measures presented here may not be comparable to similarly titled measures presented by other companies. Other companies may calculate similarly titled measures differently, limiting their usefulness as comparative measures to the Company’s data. Beike encourages investors and others to review its financial information in its entirety and not rely on a single financial measure. Adjusted income (loss) from operations is defined as income (loss) from operations, excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from acquisitions and business cooperation agreement, and (iii) impairment of goodwill, intangible assets and other long-lived assets. Adjusted operating margin is defined as adjusted income (loss) from operations as a percentage of net revenues. Adjusted net income (loss) is defined as net income (loss), excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from acquisitions and business cooperation agreement, (iii) changes in fair value from long-term investments, loan receivables measured at fair value and contingent consideration, (iv) impairment of goodwill, intangible assets and other long-lived assets, (v) impairment of investments, and (vi) tax effects of the above non-GAAP adjustments. Adjusted net income (loss) attributable to KE Holdings Inc.’s ordinary shareholders is defined as net income (loss) attributable to KE Holdings Inc.’s ordinary shareholders, excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from acquisitions and business cooperation agreement, (iii) changes in fair value from long-term investments, loan receivables measured at fair value and contingent consideration, (iv) impairment of goodwill, intangible assets and other long-lived assets, (v) impairment of investments, (vi) tax effects of the above non-GAAP adjustments, and (vii) effects of non-GAAP adjustments on net income (loss) attributable to non-controlling interests shareholders. Adjusted EBITDA is defined as net income (loss), excluding (i) income tax expense, (ii) share-based compensation expenses, (iii) amortization of intangible assets, (iv) depreciation of property, plant and equipment, (v) interest income, net, (vi) changes in fair value from long-term investments, loan receivables measured at fair value and contingent consideration, (vii) impairment of goodwill, intangible assets and other long-lived assets, and (viii) impairment of investments. Adjusted net income (loss) per ADS attributable to KE Holdings Inc.’s ordinary shareholders is defined as adjusted net income (loss) attributable to KE Holdings Inc.’s ordinary shareholders divided by weighted average number of ADS outstanding during the periods used in calculating adjusted net income (loss) per ADS, basic and diluted.

Please see the “Unaudited reconciliation of GAAP and non-GAAP results” included in this press release for a full reconciliation of each non-GAAP measure to its respective comparable GAAP measure.

About KE Holdings Inc.

KE Holdings Inc. is a leading integrated online and offline platform for housing transactions and services. The Company is a pioneer in building the infrastructure and standards to reinvent how service providers and customers efficiently navigate and complete housing transactions and services in China, ranging from existing and new home sales, home rentals, to home renovation and furnishing, and other services. The Company owns and operates Lianjia, China’s leading real estate brokerage brand in respect of service quality and an integral part of its Beike platform. With more than 24 years of operating experience through Lianjia since its inception in 2001, the Company believes the success and proven track record of Lianjia pave the way to build the infrastructure and standards and drive the rapid and sustainable growth of Beike.

Safe Harbor Statement

This press release contains statements that may constitute “forward-looking” statements pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “likely to,” and similar statements. Among other things, the quotations from management in this press release, as well as Beike’s strategic and operational plans, contain forward-looking statements. Beike may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the “SEC”) and The Stock Exchange of Hong Kong Limited (the “Hong Kong Stock Exchange”), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about KE Holdings Inc.’s beliefs, plans, and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: Beike’s goals and strategies; Beike’s future business development, financial condition and results of operations; expected changes in the Company’s revenues, costs or expenditures; Beike’s ability to empower services and facilitate transactions on Beike platform; competition in the industry in which Beike operates; relevant government policies and regulations relating to the industry; Beike’s ability to protect the Company’s systems and infrastructures from cyber-attacks; Beike’s dependence on the integrity of brokerage brands, stores and agents on the Company’s platform; general economic and business conditions in China and globally; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in KE Holdings Inc.’s filings with the SEC and the Hong Kong Stock Exchange. All information provided in this press release is as of the date of this press release, and KE Holdings Inc. does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

For more information, please visit: https://investors.ke.com.

For investor and media inquiries, please contact:

In China:
KE Holdings Inc.
Investor Relations
Siting Li
E-mail: [email protected]

Piacente Financial Communications
Jenny Cai
Tel: +86-10-6508-0677
E-mail: [email protected]

In the United States:
Piacente Financial Communications
Brandi Piacente
Tel: +1-212-481-2050
E-mail: [email protected]

Source: KE Holdings Inc.

KE Holdings Inc.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS 
(All amounts in thousands, except for share, per share data)
       As of
December 31, As of
June 30,  2025 2026  RMB RMB US$       ASSETS      Current assets      Cash and cash equivalents 7,773,182 7,387,006 1,088,710Restricted cash 8,170,605 9,039,096 1,332,198Short-term investments 39,579,961 39,585,933 5,834,245Financing receivables, net of allowance for credit losses of RMB174,478 and RMB182,002 as of December 31, 2025 and June 30, 2026, respectively 1,353,682 2,551,794 376,088Accounts receivable and contract assets, net of allowance for credit losses of RMB1,612,202 and RMB1,791,091 as of December 31, 2025 and June 30, 2026, respectively 3,936,976 4,928,874 726,426Amounts due from and prepayments to related parties 409,867 417,792 61,575Short-term loan receivables from related parties 315,755 40,853 6,021Inventories 2,854,034 2,841,717 418,817Prepayments, receivables and other assets 3,726,128 3,554,272 523,834Total current assets 68,120,190 70,347,337 10,367,914Non-current assets      Property, plant and equipment, net 2,069,624 1,866,925 275,151Right-of-use assets 19,144,129 13,267,588 1,955,401Long-term investments, net 20,148,524 19,586,382 2,886,676Intangible assets, net 722,676 659,979 97,269Goodwill 4,660,360 4,660,360 686,852Long-term loan receivables from related parties 39,573 15,019 2,214Other non-current assets 1,763,102 1,973,609 290,873Total non-current assets 48,547,988 42,029,862 6,194,436TOTAL ASSETS 116,668,178 112,377,199 16,562,350 KE Holdings Inc.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Continued)
(All amounts in thousands, except for share, per share data)       As of
December 31, As of
June 30,  2025 2026  RMB RMB US$       LIABILITIES      Current liabilities      Accounts payable 6,052,129 6,099,579 898,967Amounts due to related parties 348,467 351,075 51,742Short-term loan payable to related parties 497,939 1,081,598 159,408Employee compensation and welfare payable 6,504,197 4,823,321 710,870Customer deposits payable 4,157,248 5,685,233 837,900Income taxes payable 702,607 1,039,826 153,251Short-term borrowings 207,717 85,807 12,646Long-term borrowings, current portion - 191,689 28,251Lease liabilities, current portion 10,658,576 7,898,221 1,164,054Contract liabilities and deferred revenue 5,690,293 6,914,203 1,019,027Accrued expenses and other current liabilities 7,588,077 7,112,041 1,048,186Total current liabilities 42,407,250 41,282,593 6,084,302Non-current liabilities      Deferred tax liabilities 317,209 385,384 56,799Lease liabilities, non-current portion 6,969,571 4,764,633 702,220Long-term borrowings 182,917 - -Long-term loan payable to related parties 259,249 366,249 53,978Other non-current liabilities 2,148 1,952 288Total non-current liabilities 7,731,094 5,518,218 813,285TOTAL LIABILITIES 50,138,344 46,800,811 6,897,587 KE Holdings Inc.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Continued)
(All amounts in thousands, except for share, per share data)
       As of
December 31, As of
June 30,  2025
 2026
  RMB RMB US$       SHAREHOLDERS’ EQUITY      KE Holdings Inc. shareholders’ equity      Ordinary shares (US$0.00002 par value; 25,000,000,000 ordinary shares authorized, comprising of 24,114,698,720 Class A ordinary shares and 885,301,280 Class B ordinary shares as of both December 31, 2025 and June 30, 2026. 3,366,778,024 Class A ordinary shares issued and 3,233,808,859 Class A ordinary shares outstanding(1)as of December 31, 2025; 3,326,488,417 Class A ordinary shares issued and 3,191,987,682 Class A ordinary shares outstanding(1)as of June 30, 2026; and 139,447,770 and 135,950,651 Class B ordinary shares issued and outstanding as of December 31, 2025 and June 30, 2026, respectively) 450  443  65 Treasury shares (848,433) (571,181) (84,182)Additional paid-in capital 64,802,176  61,614,341  9,080,830 Statutory reserves 1,054,872  1,054,872  155,469 Accumulated other comprehensive income (loss) 290,029  (271,637) (40,034)Retained earnings 1,142,194  3,690,039  543,844 Total KE Holdings Inc. shareholders' equity 66,441,288  65,516,877  9,655,992 Non-controlling interests 88,546  59,511  8,771 TOTAL SHAREHOLDERS' EQUITY 66,529,834  65,576,388  9,664,763 TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY 116,668,178  112,377,199  16,562,350            (1)  Excluding (i) the Class A ordinary shares issued to the depositary bank for the bulk issuance of ADSs reserved for future issuance upon the exercise or vesting of awards granted under our share incentive plans, and (ii) the Class A ordinary shares repurchased but not cancelled, comprising both the ADSs repurchased on the NYSE and the Class A ordinary shares repurchased on the HKEX.

KE Holdings Inc.
UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
(All amounts in thousands, except for share, per share data, ADS and per ADS data)
  For the Three Months Ended For the Six Months Ended June 30,
2025 June 30,
2026 June 30,
2026 June 30,
2025 June 30,
2026 June 30,
2026 RMB RMB US$ RMB RMB US$            Net revenues           Existing home transaction services6,719,345  7,022,942  1,035,054  13,589,752  13,154,976  1,938,804 New home transaction services8,619,323  8,946,805  1,318,596  16,694,318  14,033,673  2,068,307 Home renovation and furnishing4,565,354  3,190,501  470,222  7,510,797  5,529,599  814,962 Home rental services5,674,624  4,833,122  712,314  10,762,400  9,845,823  1,451,095 Emerging and other services431,990  546,100  80,485  781,716  867,376  127,835 Total net revenues26,010,636  24,539,470  3,616,671  49,338,983  43,431,447  6,401,003 Cost of revenues           Commission-split(5,932,431) (5,796,363) (854,278) (11,625,571) (9,316,132) (1,373,028)Commission and compensation-internal(4,729,219) (4,503,398) (663,719) (9,547,496) (8,460,778) (1,246,964)Cost of home renovation and furnishing(3,098,710) (1,927,048) (284,012) (5,084,666) (3,419,236) (503,933)Cost of home rental services(5,200,202) (4,094,810) (603,500) (9,946,258) (8,366,039) (1,233,002)Cost related to stores(761,941) (564,435) (83,187) (1,478,750) (1,135,933) (167,416)Others(588,343) (639,662) (94,275) (1,135,560) (1,159,600) (170,904)Total cost of revenues(1)(20,310,846) (17,525,716) (2,582,971) (38,818,301) (31,857,718) (4,695,247)Gross profit5,699,790  7,013,754  1,033,700  10,520,682  11,573,729  1,705,756 Operating expenses           Sales and marketing expenses(1)(1,897,988) (1,402,055) (206,637) (3,670,945) (2,484,199) (366,126)General and administrative expenses(1)(2,080,713) (2,036,776) (300,184) (3,954,473) (3,749,322) (552,582)Research and development expenses(1)(633,442) (548,712) (80,870) (1,217,052) (1,041,277) (153,465)Impairment of goodwill, intangible assets and other long-lived assets(28,191) -  -  (28,191) -  - Total operating expenses(4,640,334) (3,987,543) (587,691) (8,870,661) (7,274,798) (1,072,173)Income from operations1,059,456  3,026,211  446,009  1,650,021  4,298,931  633,583 Interest income, net223,940  126,515  18,646  492,508  261,462  38,535 Share of results of equity investees6,971  613  90  14,316  (15,789) (2,327)Fair value changes in investments, net111,740  75,976  11,197  222,226  211,757  31,209 Impairment loss for equity investments accounted for using Measurement Alternative(1,214) (284) (42) (1,214) (855) (126)Foreign currency exchange (loss) gain(5,314) 15,118  2,228  (44,947) 13,655  2,012 Other income, net322,552  328,846  48,466  767,999  635,558  93,670 Income before income tax expense1,718,131  3,572,995  526,594  3,100,909  5,404,719  796,556 Income tax expense(411,487) (949,117) (139,883) (938,942) (1,525,764) (224,870)Net income1,306,644  2,623,878  386,711  2,161,967  3,878,955  571,686  KE Holdings Inc.
UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (Continued)
(All amounts in thousands, except for share, per share data, ADS and per ADS data)
     For the Three Months Ended For the Six Months Ended June 30,
2025 June 30,
2026 June 30,
2026 June 30,
2025 June 30,
2026 June 30,
2026 RMB RMB US$ RMB RMB US$            Net income attributable to non-controlling interests shareholders(5,573) (998) (147) (5,129) (584) (86)Net income attributable to KE Holdings Inc.1,301,071  2,622,880  386,564  2,156,838  3,878,371  571,600 Net income attributable to KE Holdings Inc.’s ordinary shareholders1,301,071  2,622,880  386,564  2,156,838  3,878,371  571,600             Net income1,306,644  2,623,878  386,711  2,161,967  3,878,955  571,686 Currency translation adjustments(53,412) (307,189) (45,274) (77,107) (582,671) (85,875)Unrealized(losses) gains on available-for-sale investments, net of reclassification(25,383) 15,116  2,228  6,092  21,005  3,096 Total comprehensive income1,227,849  2,331,805  343,665  2,090,952  3,317,289  488,907 Comprehensive income attributable to non-controlling interests shareholders(5,573) (998) (147) (5,129) (584) (86)Comprehensive income attributable to KE Holdings Inc.1,222,276  2,330,807  343,518  2,085,823  3,316,705  488,821 Comprehensive income attributable to KE Holdings Inc.’s ordinary shareholders1,222,276  2,330,807  343,518  2,085,823  3,316,705  488,821  KE Holdings Inc.
UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (Continued)
(All amounts in thousands, except for share, per share data, ADS and per ADS data)             For the Three Months Ended  For the Six Months Ended June 30,
2025 June 30,
2026 June 30,
2026 June 30,
2025 June 30,
2026 June 30,
2026 RMB RMB US$ RMB RMB US$            Weighted average number of ordinary shares used in computing net income per share, basic and diluted           —Basic3,357,155,883 3,235,195,371 3,235,195,371 3,359,945,551 3,255,466,680 3,255,466,680—Diluted3,507,278,161 3,354,634,458 3,354,634,458 3,514,649,718 3,378,674,991 3,378,674,991            Weighted average number of ADS used in computing net income per ADS, basic and diluted           —Basic1,119,051,961 1,078,398,457 1,078,398,457 1,119,981,850 1,085,155,560 1,085,155,560—Diluted1,169,092,720 1,118,211,486 1,118,211,486 1,171,549,906 1,126,224,997 1,126,224,997            Net income per share attributable to KE Holdings Inc.'s ordinary shareholders           —Basic0.39 0.81 0.12 0.64 1.19 0.18—Diluted0.37 0.78 0.11 0.61 1.15 0.17            Net income per ADS attributable to KE Holdings Inc.'s ordinary shareholders           —Basic1.16 2.43 0.36 1.93 3.57 0.53—Diluted1.11 2.35 0.35 1.84 3.44 0.51            (1) Includes share-based compensation expenses as follows:  Cost of revenues94,457 161,465 23,797 204,015 257,637 37,971Sales and marketing expenses35,807 68,172 10,047 81,102 107,955 15,911General and administrative expenses317,474 274,380 40,439 648,677 479,920 70,731Research and development expenses41,490 35,030 5,163 82,603 59,587 8,782 KE Holdings Inc.
UNAUDITED RECONCILIATION OF GAAP AND NON-GAAP RESULTS
(All amounts in thousands, except for share, per share data, ADS and per ADS data)     For the Three Months Ended  For the Six Months Ended June 30,
2025 June 30,
2026 June 30,
2026 June 30,
2025 June 30,
2026 June 30,
2026 RMB RMB US$ RMB RMB US$            Income from operations1,059,456   3,026,211   446,009   1,650,021   4,298,931   633,583  Share-based compensation expenses489,228  539,047  79,446  1,016,397  905,099  133,395 Amortization of intangible assets resulting from acquisitions and business cooperation agreement29,883  26,684  3,933  59,766  53,368  7,865 Impairment of goodwill, intangible assets and other long-lived assets28,191  -  -  28,191  -  - Adjusted income from operations1,606,758   3,591,942   529,388   2,754,375   5,257,398   774,843              Net income1,306,644   2,623,878   386,711   2,161,967   3,878,955   571,686  Share-based compensation expenses489,228  539,047  79,446  1,016,397  905,099  133,395 Amortization of intangible assets resulting from acquisitions and business cooperation agreement29,883  26,684  3,933  59,766  53,368  7,865 Changes in fair value from long-term investments, loan receivables measured at fair value and contingent consideration(27,687) 1,613  238  (40,771) (28,716) (4,232)Impairment of goodwill, intangible assets and other long-lived assets28,191  -  -  28,191  -  - Impairment of investments1,214  284  42  1,214  855  126 Tax effects on non-GAAP adjustments(6,494) (6,602) (973) (12,988) (13,204) (1,946)Adjusted net income1,820,979   3,184,904   469,397   3,213,776   4,796,357   706,894              Net income1,306,644   2,623,878   386,711   2,161,967   3,878,955   571,686  Income tax expense411,487  949,117  139,883  938,942  1,525,764  224,870 Share-based compensation expenses489,228  539,047  79,446  1,016,397  905,099  133,395 Amortization of intangible assets35,395  31,097  4,583  70,566  62,676  9,237 Depreciation of property, plant and equipment182,565  156,836  23,115  360,819  326,854  48,172 Interest income, net(223,940) (126,515) (18,646) (492,508) (261,462) (38,535)Changes in fair value from long-term investments, loan receivables measured at fair value and contingent consideration(27,687) 1,613  238  (40,771) (28,716) (4,232)Impairment of goodwill, intangible assets and other long-lived assets28,191  -  -  28,191  -  - Impairment of investments1,214  284  42  1,214  855  126 Adjusted EBITDA2,203,097   4,175,357   615,372   4,044,817   6,410,025   944,719              Net income attributable to KE Holdings Inc.’s ordinary shareholders1,301,071   2,622,880   386,564   2,156,838   3,878,371   571,600  Share-based compensation expenses489,228  539,047  79,446  1,016,397  905,099  133,395 Amortization of intangible assets resulting from acquisitions and business cooperation agreement29,883  26,684  3,933  59,766  53,368  7,865 Changes in fair value from long-term investments, loan receivables measured at fair value and contingent consideration(27,687) 1,613  238  (40,771) (28,716) (4,232)Impairment of goodwill, intangible assets and other long-lived assets28,191  -  -  28,191  -  - Impairment of investments1,214  284  42  1,214  855  126 Tax effects on non-GAAP adjustments(6,494) (6,602) (973) (12,988) (13,204) (1,946)Effects of non-GAAP adjustments on net income attributable to non-controlling interests shareholders(7) -  -  (14) -  - Adjusted net income attributable to KE Holdings Inc.’s ordinary shareholders1,815,399   3,183,906   469,250   3,208,633   4,795,773   706,808   KE Holdings Inc.
UNAUDITED RECONCILIATION OF GAAP AND NON-GAAP RESULTS (Continued)
(All amounts in thousands, except for share, per share data, ADS and per ADS data)
  For the Three Months Ended For the Six Months Ended June 30,
2025 June 30,
2026 June 30,
2026 June 30,
2025 June 30,
2026 June 30,
2026 RMB RMB US$ RMB RMB US$            Weighted average number of ADS used in computing net income per ADS, basic and diluted           —Basic1,119,051,961 1,078,398,457 1,078,398,457 1,119,981,850 1,085,155,560 1,085,155,560—Diluted1,169,092,720 1,118,211,486 1,118,211,486 1,171,549,906 1,126,224,997 1,126,224,997            Weighted average number of ADS used in calculating adjusted net income per ADS, basic and diluted           —Basic1,119,051,961 1,078,398,457 1,078,398,457 1,119,981,850 1,085,155,560 1,085,155,560—Diluted1,169,092,720 1,118,211,486 1,118,211,486 1,171,549,906 1,126,224,997 1,126,224,997            Net income per ADS attributable to KE Holdings Inc.'s ordinary shareholders           —Basic1.16 2.43 0.36 1.93 3.57 0.53—Diluted1.11 2.35 0.35 1.84 3.44 0.51            Non-GAAP adjustments to net income per ADS attributable to KE Holdings Inc.'s ordinary shareholders           —Basic0.46 0.52 0.07 0.93 0.85 0.12—Diluted0.44 0.50 0.07 0.90 0.82 0.12            Adjusted net income per ADS attributable to KE Holdings Inc.'s ordinary shareholders           —Basic1.62 2.95 0.43 2.86 4.42 0.65—Diluted1.55 2.85 0.42 2.74 4.26 0.63 KE Holdings Inc.
UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
(All amounts in thousands)
     For the Three Months Ended For the Six Months Ended June 30,
2025 June 30,
2026 June 30,
2026 June 30,
2025 June 30,
2026 June 30,
2026 RMB RMB US$ RMB RMB US$            Net cash provided by (used in) operating activities826,213  6,612,138  974,510  (3,139,058) 5,140,836  757,669 Net cash provided by (used in) investing activities1,664,823  (6,779,212) (999,132) 7,950,492  (1,765,397) (260,189)Net cash used in financing activities(6,182,037) (3,377,191) (497,740) (5,920,964) (2,874,313) (423,621)Effect of exchange rate change on cash, cash equivalents and restricted cash5,190  (6,038) (888) 40,690  (18,811) (2,774)Net (decrease) increase in cash, cash equivalents and restricted cash(3,685,811) (3,550,303) (523,250) (1,068,840) 482,315  71,085 Cash, cash equivalents and restricted cash at the beginning of the period22,918,385  19,976,405  2,944,158  20,301,414  15,943,787  2,349,823 Cash, cash equivalents and restricted cash at the end of the period19,232,574  16,426,102  2,420,908  19,232,574  16,426,102  2,420,908  KE Holdings Inc.
UNAUDITED SEGMENT CONTRIBUTION MEASURE
(All amounts in thousands)
       For the Three Months Ended  For the Six Months Ended  June 30,
2025 June 30,
2026 June 30,
2026 June 30,
2025 June 30,
2026 June 30,
2026  RMB RMB US$ RMB RMB US$Existing home transaction services            Net revenues 6,719,345  7,022,942  1,035,054  13,589,752  13,154,976  1,938,804 Commission and compensation (4,035,304) (3,787,244) (558,171) (8,287,595) (7,385,920) (1,088,549)Contribution 2,684,041  3,235,698  476,883  5,302,157  5,769,056  850,255 New home transaction services            Net revenues 8,619,323  8,946,805  1,318,596  16,694,318  14,033,673  2,068,307 Commission and compensation (6,515,885) (6,371,280) (939,010) (12,701,657) (10,149,552) (1,495,859)Contribution 2,103,438  2,575,525  379,586  3,992,661  3,884,121  572,448 Home renovation and furnishing            Net revenues 4,565,354  3,190,501  470,222  7,510,797  5,529,599  814,962 Material costs, commission and compensation (3,098,710) (1,927,048) (284,012) (5,084,666) (3,419,236) (503,933)Contribution 1,466,644  1,263,453  186,210  2,426,131  2,110,363  311,029 Home rental services            Net revenues 5,674,624  4,833,122  712,314  10,762,400  9,845,823  1,451,095 Property leasing costs, commission and compensation (5,200,202) (4,094,810) (603,500) (9,946,258) (8,366,039) (1,233,002)Contribution 474,422  738,312  108,814  816,142  1,479,784  218,093 Emerging and other services            Net revenues 431,990  546,100  80,485  781,716  867,376  127,835 Commission and compensation (110,461) (141,237) (20,816) (183,815) (241,438) (35,584)Contribution 321,529  404,863  59,669  597,901  625,938  92,251  KE Holdings Inc.
UNAUDITED SEGMENT CONTRIBUTION MEASURE (Continued)
(All amounts in thousands)
       For the Three Months Ended For the Six Months Ended  June 30,
2025 June 30,
2026 June 30,
2026 June 30,
2025 June 30,
2026 June 30,
2026  RMB RMB US$ RMB RMB US$Reconciliation ofprofit            Cost related to stores (761,941) (564,435) (83,187) (1,478,750) (1,135,933) (167,416)Other costs (588,343) (639,662) (94,275) (1,135,560) (1,159,600) (170,904)Amounts not allocated to segment:            Sales and marketing expenses (1,897,988) (1,402,055) (206,637) (3,670,945) (2,484,199) (366,126)General and administrative expenses (2,080,713) (2,036,776) (300,184) (3,954,473) (3,749,322) (552,582)Research and development expenses (633,442) (548,712) (80,870) (1,217,052) (1,041,277) (153,465)Impairment of goodwill, intangible assets and other long-lived assets (28,191) -  -  (28,191) -  - Total operating expenses (4,640,334) (3,987,543) (587,691) (8,870,661) (7,274,798) (1,072,173)Income from operations 1,059,456  3,026,211  446,009  1,650,021  4,298,931  633,583  _______________________________ 

1 GTV for a given period is calculated as the total value of all transactions which the Company facilitated on the Company’s platform and evidenced by signed contracts as of the end of the period, including the value of the existing home transactions, new home transactions, home renovation and furnishing and emerging and other services (excluding home rental services), and including transactions that are contracted but pending closing at the end of the relevant period. For the avoidance of doubt, for transactions that failed to close afterwards, the corresponding GTV represented by these transactions will be deducted accordingly.
2 Adjusted net income (loss) is a non-GAAP financial measure, which is defined as net income (loss), excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from acquisitions and business cooperation agreement, (iii) changes in fair value from long-term investments, loan receivables measured at fair value and contingent consideration, (iv) impairment of goodwill, intangible assets and other long-lived assets, (v) impairment of investments, and (vi) tax effects of the above non-GAAP adjustments. Please refer to the section titled “Unaudited reconciliation of GAAP and non-GAAP results” for details.
3 Based on our accumulated operational experience, we have introduced the operating metrics of number of active stores and number of active agents on our platform, which can better reflect the operational activeness of stores and agents on our platform.
“Active stores” as of a given date is defined as stores on our platform excluding the stores which (i) have not facilitated any housing transaction during the preceding 60 days, (ii) do not have any agent who has engaged in any critical steps in housing transactions (including but not limited to introducing new properties, attracting new customers and conducting property showings) during the preceding seven days, or (iii) have not been visited by any agent during the preceding 14 days.
4 “Active agents” as of a given date is defined as agents on our platform excluding the agents who (i) delivered notice to leave but have not yet completed the exit procedures, (ii) have not engaged in any critical steps in housing transactions (including but not limited to introducing new properties, attracting new customers and conducting property showings) during the preceding 30 days, or (iii) have not participated in facilitating any housing transaction during the preceding three months.
5 “Mobile monthly active users” or “mobile MAU” are to the sum of (i) the number of accounts that have accessed our platform through our Beike or Lianjia mobile app (with duplication eliminated) at least once during a month, and (ii) the number of Weixin users that have accessed our platform through our Weixin mini Programs at least once during a month. Average mobile MAU for any period is calculated by dividing (i) the sum of the Company’s mobile MAUs for each month of such period, by (ii) the number of months in such period.
6 Adjusted income (loss) from operations is a non-GAAP financial measure, which is defined as income (loss) from operations, excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from acquisitions and business cooperation agreement, and (iii) impairment of goodwill, intangible assets and other long-lived assets. Please refer to the section titled “Unaudited reconciliation of GAAP and non-GAAP results” for details. 
7 Adjusted operating margin is adjusted income (loss) from operations as a percentage of net revenues.
8 Adjusted EBITDA is a non-GAAP financial measure, which is defined as net income (loss), excluding (i) income tax expense, (ii) share-based compensation expenses, (iii) amortization of intangible assets, (iv) depreciation of property, plant and equipment, (v) interest income, net, (vi) changes in fair value from long-term investments, loan receivables measured at fair value and contingent consideration, (vii) impairment of goodwill, intangible assets and other long-lived assets, and (viii) impairment of investments. Please refer to the section titled “Unaudited reconciliation of GAAP and non-GAAP results” for details. 
9 Adjusted net income (loss) attributable to KE Holdings Inc.’s ordinary shareholders is a non-GAAP financial measure, which is defined as net income (loss) attributable to KE Holdings Inc.’s ordinary shareholders, excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from acquisitions and business cooperation agreement, (iii) changes in fair value from long-term investments, loan receivables measured at fair value and contingent consideration, (iv) impairment of goodwill, intangible assets and other long-lived assets, (v) impairment of investments, (vi) tax effects of the above non-GAAP adjustments, and (vii) effects of non-GAAP adjustments on net income (loss) attributable to non-controlling interests shareholders. Please refer to the section titled “Unaudited reconciliation of GAAP and non-GAAP results” for details.
10 ADS refers to American Depositary Share. Each ADS represents three Class A ordinary shares of the Company. Net income (loss) per ADS attributable to KE Holdings Inc.’s ordinary shareholders is net income (loss) attributable to ordinary shareholders divided by weighted average number of ADS outstanding during the periods used in calculating net income (loss) per ADS, basic and diluted.
11 Adjusted net income (loss) per ADS attributable to KE Holdings Inc.’s ordinary shareholders is a non-GAAP financial measure, which is defined as adjusted net income (loss) attributable to KE Holdings Inc.’s ordinary shareholders divided by weighted average number of ADS outstanding during the periods used in calculating adjusted net income (loss) per ADS, basic and diluted. Please refer to the section titled “Unaudited reconciliation of GAAP and non-GAAP results” for details.

Bank of New York Mellon Corp purchased a new stake in shares of CME Group Inc. (NASDAQ:CME – Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 3,927,516 shares of the financial services provider’s stock, valued at approximately $867,313,000. Bank of New York Mellon Corp owned approximately 1.09% of CME Group at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Whipplewood Advisors LLC grew its holdings in CME Group by 2,075.0% during the 1st quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 83 shares during the last quarter. Elkhorn Partners Limited Partnership bought a new position in CME Group during the 4th quarter worth $27,000. Hilton Head Capital Partners LLC bought a new position in CME Group during the 4th quarter worth $28,000. Legacy Wealth Managment LLC ID lifted its holdings in CME Group by 191.9% during the 4th quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock worth $29,000 after buying an additional 71 shares during the period. Finally, Anfield Capital Management LLC lifted its holdings in CME Group by 197.4% during the 4th quarter. Anfield Capital Management LLC now owns 113 shares of the financial services provider’s stock worth $31,000 after buying an additional 75 shares during the period. 87.75% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades CME has been the subject of a number of recent analyst reports. Wall Street Zen downgraded shares of CME Group from a “sell” rating to a “strong sell” rating in a research report on Saturday, August 1st. Barclays dropped their price target on shares of CME Group from $316.00 to $270.00 and set an “equal weight” rating on the stock in a research report on Thursday, July 9th. Bank of America upped their price objective on shares of CME Group from $226.00 to $230.00 and gave the company an “underperform” rating in a research note on Thursday, July 23rd. The Goldman Sachs Group lowered their target price on shares of CME Group from $267.00 to $245.00 and set a “sell” rating for the company in a research note on Tuesday, June 30th. Finally, Rothschild & Co Redburn raised shares of CME Group from a “neutral” rating to a “buy” rating and upped their price target for the company from $316.00 to $323.00 in a research report on Thursday, June 11th. Nine investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat, CME Group has a consensus rating of “Hold” and an average target price of $288.56.

View Our Latest Analysis on CME Group Insiders Place Their Bets In other news, Director William R. Shepard purchased 325 shares of the company’s stock in a transaction that occurred on Thursday, June 25th. The shares were acquired at an average cost of $230.57 per share, with a total value of $74,935.25. Following the purchase, the director owned 260,442 shares in the company, valued at $60,050,111.94. This represents a 0.12% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 0.30% of the company’s stock.

CME Group Trading Up 1.5% NASDAQ:CME opened at $270.87 on Friday. CME Group Inc. has a 12 month low of $218.31 and a 12 month high of $329.16. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The stock has a market capitalization of $97.40 billion, a price-to-earnings ratio of 22.97, a PEG ratio of 3.11 and a beta of 0.23. The firm has a fifty day simple moving average of $251.06 and a two-hundred day simple moving average of $279.68.

CME Group (NASDAQ:CME – Get Free Report) last announced its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, beating the consensus estimate of $2.91 by $0.08. The firm had revenue of $1.71 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The business’s quarterly revenue was up .8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.96 earnings per share. Analysts expect that CME Group Inc. will post 12.27 EPS for the current fiscal year.

CME Group Dividend Announcement The company also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Investors of record on Wednesday, September 9th will be given a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date of this dividend is Wednesday, September 9th. CME Group’s payout ratio is presently 44.11%.

About CME Group (Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

Further Reading Five stocks we like better than CME Group 3 Energy Stocks Raising Dividends as the Sector Surges 5 Reasons the S&P 500 Could Keep Rallying Through Year-End Walmart’s Post-Earnings Drop Could Be a Buying Opportunity The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Key Takeaways Targa Resources nears a 52-week high, fueled by strong Permian demand and a 20-year ExxonMobil deal.TRGP's record Permian volumes and growth projects support long-term EBITDA and free-cash-flow growth.Targa Resources faces high capital growth spending, moderating marketing gains and commodity exposure. Shares of Targa Resources Corp. (TRGP - Free Report) closed at $297.77 on Tuesday, near its 52-week high of $305.08, following a surge of 85.2% in a year. The stock price rally was followed by a positive long-term agreement with ExxonMobil Holdings Corporation (XOM - Free Report) across the Permian. During the same time period, the company’s shares outperformed the sub-industry and the broader oil and energy sector’s rise of 51.6% and 37.6%, respectively.

Peer comparison further highlights the strength, as Targa Resources conveniently outpaced its peers: Sunoco LP (SUN - Free Report) and Western Midstream Partners, LP (WES - Free Report) , which climbed 48.8% and 30.4%, respectively, in the past year.

TRGP Outperforms Industry, Sector & Peer Companies (SUN & WES)
Image Source: Zacks Investment Research

Targa Resources continues to benefit from strong demand for its Permian and Gulf Coast midstream network, enabling the company to convert this demand into steady and durable cash flows. Headquartered in Houston, TX, Targa Resources operates at the center of the U.S. midstream energy infrastructure and delivers essential services across the natural gas and natural gas liquids (NGL) value chain. Its operations include gathering, treating, compressing, processing, transporting and storing these resources. The company runs its business through two main segments — Gathering & Processing and Logistics & Transportation. A significant portion of Targa Resources’ revenues comes from fee-based contracts, which help provide a relatively stable income stream even during periods of commodity price volatility.

That said, investors are now weighing whether TRGP’s strong rally still has room to continue or if much of its future growth is already priced into the stock. With solid momentum and an encouraging outlook, the company’s prospects merit a closer look before deciding whether to buy, hold or lock in profits.

Factors Favoring Targa Resources StockLong-Term Growth Visibility From ExxonMobil Agreements: Targa Resources’ new 20-year agreements with ExxonMobil provide strong long-term volume visibility and reinforce its growth outlook. The contracts add significant acreage dedications across the Permian Delaware and Midland basins, covering gathering, processing, treating, NGL transportation and fractionation through 2046. The agreements are expected to drive substantial volume growth across TRGP’s integrated infrastructure and support growth well into the next decade. New processing plants and the Bull Run II pipeline further position the company to capture rising Permian production, supporting durable and growing adjusted free cash flow.

A Positive 2026 Earnings Estimate: The Zacks Consensus Estimate for TRGP’s 2026 earnings is pegged at $11.01 per share, indicating 29.7% year-over-year growth. Additionally, the consensus mark for 2026 revenues is pegged at $19.12 billion, also implying a 12.3% year-over-year rise. The positive earnings estimate outlook makes the stock attractive for investors. In comparison to Targa Resources, the Zacks Consensus Estimate of the above-mentioned peer companies, namely Sunoco and Western Midstream, also indicates positive year-over-year growth for 2026.

TRGP’s Earnings Estimate Overview
Image Source: Zacks Investment Research

Strong Permian Volume Growth Supports Long-Term Earnings: Targa Resources is benefiting from robust producer activity across the Permian Basin, with second-quarter volumes reaching a record 7.2 Bcf/d, up 7% sequentially and 14% year over year. Despite 200-400 MMcf/d of gas being shut in during the quarter because of weak Waha prices, volumes still increased by 450 MMcf/d from the first quarter. Most price-related curtailments returned in July, while producer activity remains strong. Targa Resources expects continued volume growth through the second half of 2026 and into 2027, supported by improving gas prices and better takeaway capacity. This growing throughput should support its gathering, processing and downstream businesses.

Major Growth Projects Could Drive Significant Future EBITDA: Targa Resources has a substantial portfolio of organic projects that should expand its processing, transportation, fractionation and export capacity. Five Permian processing plants — Copperhead I and II, Yeti I and II, and Roadrunner III — are on track, while East Driver has already started operations ahead of schedule. Train 11 is online and highly utilized, with Trains 12 and 13 progressing. Speedway and the LPG export expansion are expected in the third quarter of 2027 and should provide meaningful operating leverage. Management expects these investments to support a strong EBITDA and free-cash-flow inflection over time.

TRGP: Risks to WatchHigh Growth Capital Spending Could Pressure Free Cash Flow: Targa Resources' growth opportunity requires substantial capital investment, which could constrain free cash flow and shareholder returns in the near term. The company updated its 2026 growth capital spending to $5 billion (revised from the previously mentioned $4.5 billion in its second-quarter results) to incorporate the expected investment in the new Delaware processing plants, incremental associated field capital and the Bull Run II natural gas pipeline. Although these investments are designed to generate high returns and support future EBITDA growth, the scale of spending means the company remains heavily dependent on successful project execution and continued volume growth. Management itself expects the more meaningful free-cash-flow inflection to occur only after major projects such as Speedway and the LPG export expansion come online in the third quarter of 2027.

Marketing Gains Are Likely to Moderate: A significant portion of TRGP's exceptional first-half performance came from market optimization opportunities that were not incorporated into its original guidance. Management indicated that the first half benefited from approximately $250 million of optimization margin, but expects materially lower marketing opportunities in the second half as basis spreads narrow and Waha gas prices improve. Management specifically acknowledged that the third quarter will face a headwind from weaker marketing benefits compared with the second quarter. Therefore, investors should not assume that the unusually strong marketing contribution seen earlier in 2026 will continue at the same level.

Commodity Prices Still Create Some Earnings Exposure: Although Targa Resources has increasingly shifted its G&P contracts toward fee-based structures, part of its portfolio remains commodity-sensitive. Management noted that commodity prices were a slight headwind to G&P results during the second quarter, while the company also remains below aggregate fee-floor levels across its portfolio. A sustained improvement in gas and NGL prices could eventually provide a tailwind, but near-term earnings remain exposed to commodity-price movements and the balance between gas, NGL and crude economics. This creates some uncertainty around per-unit margins even when physical volumes continue to grow strongly.

TRGP’s Premium Valuation: From a valuation perspective — in terms of Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization (EV/EBITDA) ratio — Targa Resources is trading at a premium of 15.24 compared with the industry average of 12.35. The stock is also trading above its five-year mean of 12.02.

TRGP’s Valuation
Image Source: Zacks Investment Research

ConclusionTarga Resources remains a compelling midstream growth story, supported by its 20-year agreements with ExxonMobil, which provide strong long-term volume visibility along with strong stock performance as compared to peers like SUN and WES, while record Permian volumes and robust producer activity also support sustained growth. A substantial pipeline of processing, fractionation and export projects, along with positive 2026 earnings and revenue estimates, should strengthen EBITDA and free cash flow over time.

However, these opportunities come with meaningful risks. TRGP’s high 2026 growth capital spending could constrain near-term free cash flow and make returns dependent on successful project execution. In addition, marketing gains are expected to moderate, while commodity-price exposure could create earnings volatility. The stock also trades at a premium valuation against its industry average.

Given the company's attractive long-term growth prospects but limited margin for error at current valuation levels, retaining this Zacks Rank #3 (Hold) company appears prudent. Existing investors can benefit from future growth execution, while new investors may prefer to wait for a more attractive entry point or greater visibility on project returns and volume growth.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

(We are reissuing this article to correct a mistake. The original article, issued on August 19, 2026, should no longer be relied upon.) 

Fueled by cutting-edge Nvidia chips, data centers require more energy than ever before. As a result, the search for reliable power solutions is urgent. And because utility interconnection times can take years, hyperscalers are scrambling to find quickly deployable solutions.

Bloom Energy's (BE -2.01%) solid-oxide fuel cells have been likened to "Lego blocks" because they are factory-manufactured and transported on-site to meet the power requirements of data centers and other customers.

The "Lego" concept is at the heart of Bloom's investment thesis, and the company is experiencing historic demand as a result, sending the stock skyrocketing 2,078% since November 2024.

Today's Change

(

-2.01

%) $

-4.15

Current Price

$

202.48

Bloom Energy's "Lego block" fuel cells provide a tremendous competitive advantage Bloom Energy's high-temperature solid-oxide fuel cells are standardized, and this architecture enables these fuel cell systems to be stacked and scaled to support power deployments of up to hundreds of megawatts (MW). Because of its design and manufacturing processes, Bloom can manufacture, ship, and deploy its fuel cells in months rather than years.

The modular design not only makes deployment easier but also helps Bloom mitigate project risks. If construction on one site faces delays, the company can easily redirect trucks to deliver equipment elsewhere.

Image source: Bloom Energy.

An added benefit is that Bloom's modular fuel cell blocks can be serviced or replaced while the rest of the system remains online. Finally, these fuel cells can run on a variety of fuels, including abundantly available natural gas, with the option to run on hydrogen as the infrastructure for that option expands.

These features make Bloom's fuel cell technology highly appealing to companies like Brookfield Asset Management, which is investing massive amounts of capital to build out data centers, as well as hyperscalers and technology companies such as Oracle, CoreWeave, and Intel.

Bloom's revenue is booming as demand surges Bloom is experiencing a historic surge in demand, and its financials reflect this. In the second quarter, the company earned a record $1.065 billion in revenue, representing a 166% increase year over year. In addition, its blended gross margin increased 6% to 34.3%.

The company continues to score big wins. In April, Oracle committed to Bloom for a power block of up to 2.45 gigawatts at the Project Jupiter AI factory in New Mexico, replacing previously planned gas turbines and backup diesel generators with Bloom Energy Servers.

In June, Brookfield Asset Management expanded its strategic financing framework fivefold, from $5 billion to $25 billion. In addition, Bloom Energy has been selected to power Nebius's AI infrastructure build-out, including expanded funding from Industrial Development Funding of up to $1.7 billion.

Bloom Energy is seeing tremendous growth in demand for its "Lego block" fuel cells, thanks to a slew of benefits that are making them a popular choice among data center developers. As long as hyperscalers continue to invest heavily in the data center build-out, Bloom Energy should benefit.

Courtney Carlsen has positions in Bloom Energy, Nvidia, and Oracle. The Motley Fool has positions in and recommends Bloom Energy, Brookfield Asset Management, Intel, Nvidia, and Oracle. The Motley Fool has a disclosure policy.

Australian insurance broker Steadfast Group said on ​Friday it has agreed to a ‌A$7.7 billion ($5.51 billion) takeover offer by a U.S. consortium backed by investment firm KKR (KKR.N).

As ​part of the proposal, insurance distributor ​Amwins Group will acquire Steadfast's underwriting ⁠agency operations, while U.S.-based Dragoneer Investment ​will take over its broking business.

Steadfast shareholders, ​as previously announced, will receive A$6 apiece, representing a 51.9% premium since the stock's closing ​on June 9 — the last trading ​day before the company disclosed it had received a non-binding ‌proposal ⁠from Dragoneer and Amwins.

The Sydney-based company's board has unanimously recommended that shareholders vote in favour of the scheme, in ​the absence ​of a ⁠superior proposal and subject to an independent expert concluding the ​deal is in shareholders' best ​interests.

Steadfast ⁠is currently targeting to implement the scheme in December, it said in an ⁠exchange ​filing after market hours.

($1 = ​1.3968 Australian dollars)

Vectus Air Defense Systems to provide Air Defense as a Service for critical infrastructure; Swarmer — a founding partner with a 20% equity interest, contributing battle-proven air defense technologies and autonomy.  | Source: Swarmer

AUSTIN, Texas, Aug. 21, 2026 (GLOBE NEWSWIRE) -- Swarmer, Inc (“Swarmer” or the “Company”) (Nasdaq: SWMR), a drone autonomy software company which has supported more than 100,000 real-world combat missions in Ukraine since April 2024, today announced its strategic partnership with and equity investment in Vectus Air Defense Systems, a newly established company led by Erik Prince and focused on providing air defense as a service to governments and critical infrastructure operators.

Vectus Air Defense Systems will design, integrate and operate complete layered air-defense systems under multi-year contractual agreements, encompassing system architecture, equipment, personnel, operations, management and maintenance — an end-to-end managed service designed around the specific threat environment and operating requirements of each customer.

“Over the past year, I have spent considerable time in Ukraine, the Middle East, Africa and Latin America speaking with both technology suppliers and potential customers,” said Erik Prince, Founder of Vectus Air Defense Systems and Non-Executive Chairman of Swarmer, “It’s clear that the threat is evolving rapidly and the demand for a private sector solution is very strong. We need to achieve a drastic reduction in the cost of defense and to enable customers to take the protection of critical assets into their own hands. This is not just a business opportunity but a societal requirement.”

Swarmer will work closely with Vectus Air Defense Systems on the development of advanced counter-UAS capabilities, including drone interceptor swarming technology.

Vectus Air Defense Systems will integrate best-in-class, battle-tested technologies from the United States, Ukraine, Israel, and other allied nations, combining advanced detection and tracking with a layered counter-UAS architecture incorporating detection, electronic warfare, drone interceptors and large-caliber cannons with a high rate of fire. As threats and defensive technologies evolve, the systems deployed at customer sites are expected to evolve with them.

“The future of air defense will be autonomous, distributed and built around technologies that can evolve as quickly as the threats they are designed to defeat,” said Alex Fink, President and U.S. Chief Executive Officer of Swarmer. “Erik’s deep experience with defense ministries, military leaders and security institutions gives Vectus Air Defense Systems the ability to bring together the best technologies from across the market and deliver them through a new air-defense-as-a-service model. Swarmer is thrilled to be a part of it from day one.”

About Vectus Air Defense Systems

Vectus Air Defense Systems provides Air Defense as a Service for sovereign governments and critical infrastructure operators. The company designs, integrates and continuously operates layered air-defense systems under multi-year service agreements, while monitoring evolving threats and upgrading deployed systems as technologies and tactics change. Its mission is to help ensure that critical infrastructure remains operational when disruption is not an option.

About Swarmer

Swarmer™ is a defense technology company that specializes in vendor-agnostic software which allows one operator to intuitively control hundreds of autonomous platforms in real time. Swarmer’s primary mission areas include autonomous swarm coordination, integration of multi-domain unmanned systems and AI-powered autonomy software for distributed operations. Swarmer is not a drone manufacturer and does not depend on any single platform, supplier or hardware lifecycle. Instead, Swarmer operates at the intelligence layer, developing autonomy, coordination and decision-making software that enables large numbers of low-cost unmanned systems to operate collectively as one coherent, resilient force. Swarmer’s technology has been rigorously validated in real-world kinetic environments and was first deployed in combat operations in Ukraine in April 2024. Since then, it has completed more than 100,000 combat missions, generating terabytes of proprietary data that informs its machine-learning models and enables the replication of advanced pilot performance at scale. Swarmer’s routine use in combat missions generates continuous streams of telemetry, sensor data and operational feedback which are then used to refine performance, increase resilience and accelerate learning. Swarmer has headquarters in Austin, Texas, and maintains operations and teams in Ukraine, Poland and Estonia.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include statements about the anticipated strategic and financial benefits of the Company’s partnership with and equity investment in Vectus Air Defense Systems; the expected scope, capabilities and market opportunity of Vectus Air Defense Systems’ planned air defense as a service offering; Vectus Air Defense’s plans to provide multi-year managed services encompassing system architecture, equipment, personnel, operations, management and maintenance; the Company’s planned contribution of its autonomy software and technology integration capabilities to Vectus Air Defense Systems; the expected relevance of the Company’s operational learning cycles and combat data to counter-UAS and air-defense missions; the Company’s belief that Vectus Air Defense Systems can help drive down the cost per defensive effect; the Company’s plans to integrate technologies from multiple suppliers; the status of discussions with potential joint-venture partners and prospective customers; and the Company’s strategy to evaluate and pursue additional strategic opportunities.

Forward-looking statements are based on current expectations, estimates, forecasts, and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. These risks and uncertainties include, among others: the Company’s limited operating history as a public company; its history of losses and limited current revenue; customer concentration and the timing, non-renewal, or loss of customer engagements; the Company’s ability to convert pilot programs, memoranda of understanding, and development-stage relationships into binding commercial contracts or revenue; defense procurement cycles and government budget priorities; geopolitical conditions affecting operations, customers, suppliers, and deployments in Ukraine and other regions; export control, sanctions, defense trade, procurement, and other regulatory requirements; competition in the defense technology and autonomous systems markets; the Company’s ability to develop, validate, scale, and integrate its software across third-party unmanned platforms; risks associated with artificial intelligence, machine learning, data availability, data quality, cybersecurity, and operational performance in real-world environments; reliance on key personnel and technical talent; supply chain and manufacturing constraints affecting the Company’s customers or partners; and the other risks described in the Company’s filings with the Securities and Exchange Commission.

Forward-looking statements speak only as of the date of this release. The Company undertakes no obligation to update or revise any forward-looking statements, except as required by law. Additional risks and uncertainties are described in Swarmer’s filings with the Securities and Exchange Commission, including under the caption “Risk Factors” in Swarmer’s most recent registration statement, most recent Quarterly Report on Form 10-Q and other filings filed with or furnished to the SEC.

Investor Relations Contact: [email protected]

Media Relations Contact: [email protected]

BXP, Inc. (NYSE:BXP – Get Free Report) has earned an average rating of “Moderate Buy” from the twenty brokerages that are presently covering the company, Marketbeat reports. Nine research analysts have rated the stock with a hold recommendation and eleven have given a buy recommendation to the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $74.5789.

A number of research firms recently issued reports on BXP. Truist Financial dropped their target price on shares of BXP from $70.00 to $64.00 and set a “hold” rating for the company in a research report on Tuesday, May 26th. Citigroup increased their price objective on shares of BXP from $58.00 to $69.00 and gave the stock a “neutral” rating in a research report on Tuesday, August 4th. Weiss Ratings upgraded shares of BXP from a “hold (c-)” rating to a “hold (c)” rating in a report on Wednesday, July 8th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of BXP in a research report on Wednesday, August 12th. Finally, Evercore set a $68.00 price objective on BXP in a research report on Monday, July 6th.

View Our Latest Analysis on BXP

Insider Transactions at BXP In other news, CFO Michael E. Labelle sold 26,113 shares of BXP stock in a transaction that occurred on Tuesday, June 9th. The shares were sold at an average price of $66.35, for a total transaction of $1,732,597.55. Following the sale, the chief financial officer owned 5,839 shares in the company, valued at $387,417.65. This trade represents a 81.73% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.50% of the stock is owned by company insiders. Institutional Trading of BXP Hedge funds and other institutional investors have recently modified their holdings of the business. Rehmann Capital Advisory Group grew its stake in shares of BXP by 4.3% in the 2nd quarter. Rehmann Capital Advisory Group now owns 4,280 shares of the real estate investment trust’s stock valued at $284,000 after purchasing an additional 175 shares during the period. Keybank National Association OH lifted its position in shares of BXP by 5.4% during the 4th quarter. Keybank National Association OH now owns 3,578 shares of the real estate investment trust’s stock worth $241,000 after buying an additional 183 shares during the period. State of Wyoming lifted its position in shares of BXP by 45.5% during the 4th quarter. State of Wyoming now owns 617 shares of the real estate investment trust’s stock worth $42,000 after buying an additional 193 shares during the period. Minot DeBlois Advisors LLC boosted its stake in BXP by 2.5% in the 4th quarter. Minot DeBlois Advisors LLC now owns 7,902 shares of the real estate investment trust’s stock valued at $533,000 after buying an additional 196 shares in the last quarter. Finally, Rexford Capital Inc. boosted its stake in BXP by 11.9% in the 4th quarter. Rexford Capital Inc. now owns 1,876 shares of the real estate investment trust’s stock valued at $127,000 after buying an additional 200 shares in the last quarter. 98.72% of the stock is owned by hedge funds and other institutional investors.

BXP Stock Up 1.0% Shares of NYSE BXP opened at $67.86 on Friday. The stock has a market capitalization of $10.83 billion, a PE ratio of 36.48, a P/E/G ratio of 2.51 and a beta of 1.01. The company has a quick ratio of 3.91, a current ratio of 3.91 and a debt-to-equity ratio of 2.07. The firm has a fifty day moving average of $67.85 and a 200-day moving average of $61.40. BXP has a 52-week low of $49.72 and a 52-week high of $79.33.

BXP (NYSE:BXP – Get Free Report) last issued its earnings results on Tuesday, July 28th. The real estate investment trust reported $0.43 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.03. The firm had revenue of $895.70 million for the quarter, compared to analysts’ expectations of $858.07 million. BXP had a return on equity of 3.88% and a net margin of 8.44%.The firm’s revenue for the quarter was up 3.1% compared to the same quarter last year. During the same quarter last year, the firm earned $1.71 earnings per share. BXP has set its FY 2026 guidance at 6.990-7.050 EPS and its Q3 2026 guidance at 1.800-1.820 EPS. On average, analysts anticipate that BXP will post 7.03 EPS for the current year.

BXP Dividend Announcement The business also recently declared a quarterly dividend, which was paid on Friday, July 31st. Investors of record on Tuesday, June 30th were given a dividend of $0.70 per share. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $2.80 annualized dividend and a yield of 4.1%. BXP’s payout ratio is 150.54%.

BXP Company Profile (Get Free Report)

Boston Properties, Inc (NYSE: BXP) is a publicly traded real estate investment trust (REIT) specializing in the ownership, management, and development of Class A office properties across major U.S. markets. Headquartered in Boston, Massachusetts, the company’s portfolio comprises high-quality office buildings, mixed-use developments and select retail assets designed to serve leading corporations in key metropolitan areas.

Established in 1970 by Mortimer B. Zuckerman, Boston Properties has grown through disciplined acquisitions and strategic ground-up developments.

Featured Stories Five stocks we like better than BXP 3 Energy Stocks Raising Dividends as the Sector Surges 5 Reasons the S&P 500 Could Keep Rallying Through Year-End Walmart’s Post-Earnings Drop Could Be a Buying Opportunity The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future

Receive News & Ratings for BXP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BXP and related companies with MarketBeat.com's FREE daily email newsletter.

Shares of Williams Companies, Inc. (The) (NYSE:WMB – Get Free Report) have been assigned an average rating of “Buy” from the twenty ratings firms that are presently covering the firm, Marketbeat reports. Two analysts have rated the stock with a hold recommendation, fifteen have assigned a buy recommendation and three have given a strong buy recommendation to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $85.60.

A number of brokerages have recently weighed in on WMB. Citigroup upped their price target on shares of Williams Companies from $81.00 to $83.00 and gave the stock a “buy” rating in a research note on Friday, May 8th. Morgan Stanley boosted their target price on Williams Companies from $99.00 to $103.00 and gave the stock an “overweight” rating in a report on Tuesday. Canadian Imperial Bank of Commerce upped their target price on Williams Companies from $83.00 to $85.00 and gave the stock an “outperformer” rating in a research report on Tuesday, May 26th. TD Cowen increased their price target on Williams Companies from $81.00 to $87.00 and gave the company a “buy” rating in a research note on Thursday, May 7th. Finally, Wells Fargo & Company lifted their price target on Williams Companies from $89.00 to $90.00 and gave the company an “overweight” rating in a research report on Wednesday, August 5th.

Read Our Latest Research Report on WMB

Williams Companies Price Performance Shares of WMB opened at $71.86 on Tuesday. The firm has a market capitalization of $87.90 billion, a price-to-earnings ratio of 28.63, a price-to-earnings-growth ratio of 1.51 and a beta of 0.58. The company has a debt-to-equity ratio of 1.83, a quick ratio of 0.43 and a current ratio of 0.48. Williams Companies has a one year low of $56.08 and a one year high of $80.07. The stock’s fifty day moving average is $73.40 and its 200-day moving average is $73.15. Williams Companies (NYSE:WMB – Get Free Report) last posted its quarterly earnings data on Monday, August 3rd. The pipeline company reported $0.50 earnings per share for the quarter, hitting the consensus estimate of $0.50. The business had revenue of $3.05 billion during the quarter, compared to the consensus estimate of $2.83 billion. Williams Companies had a net margin of 25.17% and a return on equity of 18.49%. The company’s quarterly revenue was up 9.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.46 earnings per share. Williams Companies has set its FY 2026 guidance at 2.350-2.350 EPS. Equities analysts anticipate that Williams Companies will post 2.48 EPS for the current year.

Williams Companies Dividend Announcement The company also recently announced a quarterly dividend, which will be paid on Monday, September 28th. Investors of record on Friday, September 11th will be paid a dividend of $0.525 per share. The ex-dividend date of this dividend is Friday, September 11th. This represents a $2.10 annualized dividend and a yield of 2.9%. Williams Companies’s dividend payout ratio (DPR) is currently 83.67%.

Insider Transactions at Williams Companies In related news, SVP Terrance Lane Wilson sold 13,000 shares of Williams Companies stock in a transaction dated Friday, August 14th. The stock was sold at an average price of $74.87, for a total transaction of $973,310.00. Following the transaction, the senior vice president directly owned 268,159 shares of the company’s stock, valued at $20,077,064.33. The trade was a 4.62% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders sold 17,000 shares of company stock worth $1,262,930 over the last quarter. 0.47% of the stock is owned by insiders.

Hedge Funds Weigh In On Williams Companies Large investors have recently made changes to their positions in the business. Vanguard Group Inc. boosted its holdings in Williams Companies by 0.7% during the fourth quarter. Vanguard Group Inc. now owns 133,963,343 shares of the pipeline company’s stock worth $8,052,537,000 after buying an additional 883,245 shares in the last quarter. State Street Corp increased its holdings in shares of Williams Companies by 1.9% in the fourth quarter. State Street Corp now owns 67,981,106 shares of the pipeline company’s stock valued at $4,086,344,000 after buying an additional 1,296,991 shares in the last quarter. Bank of America Corp DE increased its holdings in shares of Williams Companies by 4.8% in the fourth quarter. Bank of America Corp DE now owns 46,053,873 shares of the pipeline company’s stock valued at $2,768,298,000 after buying an additional 2,100,164 shares in the last quarter. Morgan Stanley lifted its position in shares of Williams Companies by 11.0% during the 4th quarter. Morgan Stanley now owns 33,572,067 shares of the pipeline company’s stock valued at $2,018,017,000 after acquiring an additional 3,314,851 shares during the last quarter. Finally, Wellington Management Group LLP boosted its stake in shares of Williams Companies by 43.4% during the 2nd quarter. Wellington Management Group LLP now owns 33,097,208 shares of the pipeline company’s stock worth $2,460,446,000 after acquiring an additional 10,013,946 shares in the last quarter. Institutional investors own 86.44% of the company’s stock.

(Get Free Report)

Williams Companies, Inc (NYSE: WMB) is a U.S.-based energy infrastructure company focused on the midstream segment of the natural gas value chain. The company develops, owns and operates assets that gather, process, transport and store natural gas and natural gas liquids (NGLs). Its operations support the movement of gas from production areas to end users including utilities, power generators, industrial customers and export facilities.

Williams’s product and service offering includes interstate and intrastate pipeline transmission, gas-gathering systems, processing facilities that remove impurities and separate NGLs, storage services and fractionation and transportation of NGL products.

Recommended Stories Five stocks we like better than Williams Companies 3 Energy Stocks Raising Dividends as the Sector Surges 5 Reasons the S&P 500 Could Keep Rallying Through Year-End Walmart’s Post-Earnings Drop Could Be a Buying Opportunity The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future

Receive News & Ratings for Williams Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Williams Companies and related companies with MarketBeat.com's FREE daily email newsletter.

EUR/USD has broken above its 200-day average as Goldman Sachs argues Treasury support may force the Dollar to absorb more of the adjustment. The Euro to Dollar (EUR/USD) exchange rate traded around 1.1700 on Friday morning, up 0.11% on the day and 1.12% higher over the previous five sessions.

The pair has gained 2.61% over the past month, with the latest leg higher following Washington's decision to increase long-dated Treasury buybacks.

Goldman Sachs believes the policy shift matters more for the Dollar than for the underlying rates outlook.

The Treasury said it would at least double liquidity-support buybacks for longer-dated bonds to $4bn per operation, a move that initially drove the 30-year yield almost 10 basis points lower and knocked around 0.7% from the Dollar index.

Goldman's Treasury desk estimates the larger programme could amount to at least $18bn of additional long-end purchases per quarter, or $72bn annualised, with total long-end buybacks potentially reaching around $144bn a year.

Supporting Bonds Could Shift the Pressure into FX Goldman Sachs G10 FX options trader Praneet Shah argued that the move should not be read simply as a rates story.

“I do however think this is more meaningful for the USD,” Shah wrote, noting that Washington had shown it was willing to become more inventive when supporting the long end of the Treasury market.

The key risk for the currency is that policy support for bonds changes where the adjustment takes place.

“Supporting bonds may come at the expense of letting the USD become the adjustment valve,” Shah said, framing the trade-off as one between restraining yields and allowing more of the pressure to show up through the exchange rate.

That interpretation is important because the bond-market move itself may not be large enough to generate a lasting decline in yields.

Goldman's rates team expects buybacks to help cap the long end rather than drive a major repricing lower, while fiscal deficits and heavy supply remain persistent upward pressures.

For foreign exchange, however, a credible perception that the Treasury is willing to lean against long-end stress could be enough to keep the Dollar under pressure even if yields stop falling.

The EUR/USD technical picture has also shifted.

Goldman's 20 August chart showed EUR/USD around 1.1693 against a 200-day moving average near 1.1630, leaving the pair clearly above that long-term trend measure.

Shah said the break was “interesting” and highlighted the possibility of a sustained move if positioning and low volatility continue to support the Euro.

Image: ERUK's EUR/USD sentiment survey poll results for next 4 quarters 2026, into 2027 The Exchange Rates UK Research Currency Forecast Sentiment Survey currently places the median EUR/USD forecast at 1.1650 for the fourth quarter of 2026 and 1.18 for the first quarter of 2027.

That means spot is already trading above the near-term consensus median.

In our view, holding above the 1.1630-1.1650 area would keep the Goldman technical signal intact, while a clean move through 1.1710 would strengthen the case for a further advance towards the upper 1.17s.

The wider implication is more significant than a single technical break: if the Treasury increasingly tries to suppress stress in the bond market, the Dollar itself may become the release valve.

Broadcom Inc (NASDAQ:AVGO, XETRA:1YD), the US semiconductor company, is in talks to raise more than $60 billion in debt to fund a financing deal that would supply AI chips to Anthropic and other companies.

That is according to Bloomberg, which cited people familiar with the matter.

The talks point to the scale of borrowing now being lined up to build out AI computing capacity.

How the deal is structured

The financing could include a junior debt tranche of roughly $30 billion, according to the report.

A tranche is a slice of a larger borrowing, each carrying its own risk and repayment terms.

Broadcom would guarantee part of a senior-secured tranche that could range from about $60 billion to $70 billion.

Senior-secured debt ranks first for repayment and is backed by specific assets, making it lower risk than junior debt.

Taken together, the sums under discussion could bring the total raise to as much as $100 billion.

A deal of that size would rank among the largest corporate financings tied to the AI boom.

Who is involved

Blackstone and Apollo Global Management (NYSE:APO), two of the largest US private capital firms, are in talks to take part in the financing.

Their involvement would follow a partnership the three companies struck in June.

Private capital firms have moved increasingly into lending for AI infrastructure as banks reach the limits of what they will underwrite alone.

Broadcom, Apollo and Blackstone did not immediately respond to requests for comment on the Bloomberg report.

The figures under discussion have not been formally confirmed.

Why it matters for Anthropic

The deal would channel funding towards chips for Anthropic, the company behind the Claude chatbot.

Access to computing power has become one of the biggest constraints on AI companies, and securing it often requires financing on a scale usually seen in energy or infrastructure projects.

Anthropic is separately preparing to file paperwork for an initial public offering that could rival the record set by SpaceX.

Borrowing arrangements of this kind allow AI firms to lock in chip supply without carrying the full cost on their own balance sheets.

The reported talks underline how far the industry now depends on outside capital to keep pace with demand.

, /PRNewswire/ -- T. Rowe Price Group, Inc. (NASDAQ-GS: TROW), a global investment management firm, today announced an agreement to acquire F/m Investments LLC, the fixed income asset manager and ETF specialist with approximately $19 billion in assets under management as of July 31, 2026, across exchange-traded funds (ETFs), institutional separate accounts, and both taxable and municipal separately managed accounts (SMAs).

The acquisition is expected to deepen T. Rowe Price's fixed income capabilities, accelerate growth across its ETF franchise, and broaden its liquidity, cash management, and customized fixed income offerings. The transaction also reflects T. Rowe Price's disciplined approach to acquisitions and partnerships that strengthen its investment capabilities and expand scalable solutions for clients.

Founded in 2019 and headquartered in Washington, D.C., F/m Investments is an asset manager focused on delivering precise, transparent, and accessible fixed income solutions and is an affiliate of 1251 Capital Group, Inc. Its US Benchmark Series, the first standardized suite of single-security U.S. Treasury ETFs, is designed to provide maturity-specific exposure to U.S. Treasury securities through an ETF structure.

F/m's suite of 20 ETFs covers the fixed income landscape from Treasuries and TIPS to corporate bonds and municipal securities. F/m also has been a driver of innovation in the ETF industry through the launch of the first dual-share class ETF and the filing of a first-of-its-kind SEC application for tokenized ETF shares. In addition, F/m provides customized municipal bond and liquidity solutions to institutional and high-net-worth clients.

"F/m Investments is a strong strategic and cultural fit with T. Rowe Price," said Arif Husain, T. Rowe Price's Head of Global Fixed Income and a member of the firm's Management Committee. "The acquisition reflects a thoughtful, disciplined approach to expanding our capabilities in areas where we see durable client demand, clear strategic alignment, and the opportunity to create long-term value. F/m brings unique ETF product development capabilities that will complement T. Rowe Price's active fixed income lineup across our Intermediary, Institutional, Retirement, and Wealth platforms."

At closing, the acquisition is expected to increase T. Rowe Price's fixed income assets under management by nearly 9%, more than doubling its fixed income ETF assets under management and expanding its fixed income SMA business.

"We started F/m because fixed income investments were too hard for investors to use. To continue to innovate and provide client value at scale, we needed a partner with relevant expertise, deep resources, and a shared vision. T. Rowe Price has been clear that the way we work is the thing they're investing in," said Alexander Morris, CEO and Co-Founder of F/m Investments. "Our mission will remain the same. We are excited to align our approach with T. Rowe Price's scale to better serve clients for years to come."

Upon closing, F/m will operate as "F/m Investments, a T. Rowe Price Company," retaining its brand, leadership, investment approach, and day-to-day operating model. Alexander Morris will report to Arif Husain, and F/m employees will become T. Rowe Price associates. This structure preserves what has made F/m successful while extending its fixed income capabilities across T. Rowe Price's platforms.

The transaction is expected to close in early 2027, subject to customary filings and closing conditions. Financial terms were not disclosed.

Dechert LLP served as legal counsel to T. Rowe Price.

Oppenheimer & Co. Inc. acted as exclusive financial advisor to F/m Investments, and Fried, Frank, Harris, Shriver & Jacobson LLP served as legal counsel to the majority owners of F/m Investments.

ABOUT T. ROWE PRICE

T. Rowe Price (NASDAQ-GS: TROW) is a leading global asset management firm, entrusted with managing $1.87 trillion in client assets as of July 31, 2026, about two-thirds of which are retirement-related. Renowned for nearly 90 years of investment excellence, retirement leadership, and independent proprietary research, the firm leverages its longstanding expertise to ask better questions that can drive better investment decisions. Built on a culture of integrity and prioritizing client interests, T. Rowe Price empowers millions of investors worldwide to thrive amid evolving markets. Visit troweprice.com/newsroom for news and public policy commentary.

ABOUT F/m INVESTMENTS

F/m Investments is a fixed income investment advisory firm managing approximately $19 billion across ETFs, mutual funds, and separately managed accounts as of July 31, 2026. Creator of the US Benchmark Series, the first complete suite of single-security U.S. Treasury ETFs, F/m builds products designed to achieve client objectives — precisely, transparently, and with ease. Founded in 2019, F/m is headquartered in Washington, D.C.

ABOUT 1251 CAPITAL GROUP

1251 Capital Group is a financial services holding company with a permanent capital base and a long-term investment horizon. 1251 partners with high-quality businesses and management teams in the asset management and insurance sectors to help accelerate growth and build enduring franchises. The firm provides strategic resources, industry expertise and operating support while empowering its affiliates to maintain their independent and entrepreneurial cultures.

OTHER MATTERS

Statements in this press release that are not historical facts are "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. When used in this press release, words or phrases generally written in the future tense and/or preceded by words such as "will," "may," "could," "expect," "believe," "anticipate," "intend," "plan," "seek," "estimate," "preliminary," or other similar words are forward-looking statements. Various forward-looking statements in this press release relate to the acquisition by T. Rowe Price of F/m Investments, including regarding expected scale and distribution opportunities, operating efficiencies and results, growth, client and stockholder benefits, key assumptions, timing of closing of the transaction, revenue realization, financial benefits or returns, and integration costs.

Forward-looking statements involve a number of known and unknown risks, uncertainties, and other important factors, some of which are listed below, that could cause actual results and outcomes to differ materially from any future results or outcomes expressed or implied by such forward-looking statements. Important transaction-related and other risk factors that may cause such differences include: (i) the occurrence of any event, change, or other circumstances that could give rise to the termination of the purchase agreement; (ii) the transaction closing conditions may not be satisfied in a timely manner or at all, including due to the failure to obtain regulatory and client approvals; and (iii) anticipated benefits of the transaction, including the realization of revenue, accretion, financial benefits or returns, and expense and other synergies, may not be fully realized or may take longer to realize than expected.

Readers are cautioned that any forward-looking information provided by or on behalf of T. Rowe Price or F/m Investments is not a guarantee of future performance. Actual results may differ materially from those in forward-looking information because of various factors including, but not limited to, those discussed above and in Item 1A, Risk Factors, included in T. Rowe Price's Form 10-K Annual Report for 2025.

Any forward-looking statements speak only as of the date on which they are made, and neither T. Rowe Price nor F/m Investments undertakes an obligation to update any forward-looking statement to reflect events or circumstances after the date on which it is made or to reflect the occurrence of unanticipated events.

SOURCE T. Rowe Price Group

Pound-Dollar can hold above $1.36 if pressure on the US Dollar from fiscal concerns and softer Fed bets offsets any drag from weaker UK retail sales and PMI data. The Pound US Dollar (GBP/USD) exchange rate maintained a positive trajectory on Thursday, with the pairing being propelled to its best levels since mid-February.

At the time of writing, GBP/USD was trading at around $1.3646. Up around 0.3% from Thursday’s opening levels.

Latest — Exchange Rates:

Pound to Dollar (GBP/USD): 1.362643 (+0.20%)

Euro to Dollar (EUR/USD): 1.167162 (-0.02%)

Dollar to Yen (USD/JPY): 159.0647 (+0.51%)

DAILY RECAP:

The US Dollar (USD) remained under pressure on Thursday, slipping to fresh multi-month lows as concerns over the US fiscal outlook continued to weigh on sentiment towards the ‘Greenback’.

The latest warning sign came as America’s national debt surpassed the $40tn mark for the first time, reinforcing concerns over the sustainability of the country’s finances and the growing cost of servicing its debt.

The milestone came alongside ongoing volatility in the US bond market, where long-term borrowing costs had climbed sharply, forcing the US Treasury to step in and announce it would at least double the size of its planned buybacks of longer-dated government debt.

The Pound (GBP) traded with modest support on Thursday, firming on the back of the Confederation of British Industry's (CBI) latest industrial trends orders index.

The index printed at -25 this month, marking a continued contraction in order books, but a marked improvement from the -45 recorded in July and striking its best levels since late 2024.

The data points to surprising resilience in the UK manufacturing sector, despite headwinds posed by the war in the Middle East and rising energy prices.

Near-Term GBP/USD Forecast: UK retail sales and PMIs could test Sterling strength Turning to Friday's session, the Pound to US Dollar (GBP/USD) exchange rate may be pressured by the final UK economic releases of the week.

Friday's European session opens with the release of the UK's latest retail sales data, which is forecast to report a contraction in consumer spending and sap Sterling sentiment.

The subsequent publication of the UK's latest PMIs could then drag the Pound even lower, as economists forecast that growth in the UK's dominant services sector is likely to have slowed this month.

Closing out the session will be the publication of the latest US S&P PMIs. While not as influential as the ISM indexes, they could still lend the US Dollar support if they point to further resilience in the US private sector.

Exchange Rates UK Research Our currency coverage draws on live market data, official economic releases and published bank research.

3 Gold Stocks Under $5 With Massive UpsideGold Royalty NYSEAMERICAN: GROY outlined plans to expand its cash-generating royalty portfolio, projecting a 60% increase in gold equivalent ounces in 2026 and targeting roughly 30,000 gold equivalent ounces by 2030, according to Vice President of Capital Markets and Sustainability Jackie Przybylowski.

The company, founded in 2020 and publicly listed in 2021, began with 18 royalties and no revenue. Przybylowski said Gold Royalty subsequently expanded through acquisitions of Ely Gold, Golden Valley and Abitibi Royalties, adding assets including its flagship 3% royalty on Agnico Eagle’s Canadian Malartic mine in Quebec.

Get Gold Royalty alerts:

Gold Royalty now has approximately 260 assets and about 10 cash-flowing assets in its portfolio. The company’s holdings include royalties connected to the Canadian Malartic mine, the Côté Gold mine in Ontario and the Ren portion of the Nevada Gold Mines complex.

Growth outlook supported by operating and development assets Gold Royalty’s 2026 guidance calls for 7,500 to 9,300 gold equivalent ounces, representing a 60% increase at the midpoint compared with 2025 actual production, Przybylowski said. The projected growth is expected to come largely from assets that have already been built or are operating, including the Borborema and Pedra Branca royalties acquired late last year or earlier this year.

By 2030, the company expects to reach about 30,000 gold equivalent ounces annually. Przybylowski said mature operations and brownfield expansions account for 70% of the company’s expected growth, while satellite deposits such as County Line and Ren represent 90% when included.

“We are not looking for any single asset, early-stage company to really drive the growth,” Przybylowski said. “It is coming from assets that are already permitted, already financed, and already built, at least to a first phase of construction.”

She identified South Railroad and Tonopah West as examples in the advanced-development category. South Railroad, previously developed by Orla and now associated with Equinox Gold following its acquisition of Orla, has received permits and begun construction, she said. Tonopah West was generated through Gold Royalty’s Nevada land-staking model and could enter production as early as 2030, according to Przybylowski.

Gold Royalty said it does not provide annual revenue guidance beyond the stated production ranges. However, Przybylowski cited analyst consensus estimates suggesting that annual revenue could reach $120 million to $150 million by 2030 at gold prices of approximately $4,000 to $5,000 per ounce, compared with roughly $25 million currently.

Royalty generation and acquisition discipline The company described four avenues for growth: royalty financing, third-party royalty acquisitions, corporate mergers and acquisitions, and royalty generation. Its royalty-generation strategy involves staking and maintaining mining claims in Nevada, then transferring those claims to operators in exchange for upfront payments and perpetual royalties.

Przybylowski said the model requires no spending on drilling or exploration, while allowing Gold Royalty to benefit if operators later develop the properties. The company said operators across its portfolio are expected to spend several million dollars on exploration and drill more than 500,000 meters this year, activity that could create upside for the company without additional capital commitments from Gold Royalty.

When asked what limits growth, Przybylowski said the main constraint is identifying transactions that are accretive on a per-share basis. Competition for royalty opportunities can be significant, particularly when deals are broadly marketed, she said.

“We want to make sure we are not doing deals just for the sake of doing deals,” Przybylowski said. “We want to make sure they are accretive.”

She said Gold Royalty seeks bilateral or quasi-bilateral transactions where it has existing relationships, while also participating in banker-led processes and generating royalties internally.

Portfolio updates and balance sheet Przybylowski highlighted several assets that have seen changes in ownership or operational progress. Discovery acquired the Porcupine complex from Newmont in 2025 and has increased drilling and exploration activity at Borden, she said. DPM Metals acquired Adriatic Metals and has advanced the Vareš mine, which recently reached commercial production ahead of a previously cited end-of-September target.

At Vareš, Gold Royalty holds its only stream agreement, entitling it to 100% of the copper produced at the primarily silver, lead and zinc operation. The company receives payment for approximately 24% to 25% of copper produced and pays DPM Metals 30% of the copper spot price under the stream agreement, Przybylowski said.

Gold Royalty also expects potential future contributions from Odyssey, the underground portion of Canadian Malartic; Jerritt Canyon; Ren; South Railroad; and Granite Creek. The company said all its royalties are fully paid for, with no additional capital calls or project-cost exposure.

Gold Royalty reported about $200 million of available capital for potential transactions, including $150 million available under an undrawn credit facility. Przybylowski said the company is debt-free and has a positive cash position.

Management’s preference is to deploy capital toward accretive growth, though the board is considering a capital-return policy that could be implemented in early 2027. Potential options include a share repurchase program or a regular dividend, depending on the company’s valuation and share price at that time.

About Gold Royalty (NYSEAMERICAN:GROY)Gold Royalty Corp is a precious metals royalty and streaming company that focuses on acquiring and managing royalty interests in gold, silver and other metal assets. The company provides upfront funding to mining operators in exchange for a percentage of future metal production, offering an alternative financing model that can reduce capital requirements and accelerate development timelines for mining projects.

The firm's diversified portfolio spans royalty and stream agreements across the Americas, with interests in operating mines, development‐stage assets and advanced exploration projects.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Gold Royalty Right Now?Before you consider Gold Royalty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Gold Royalty wasn't on the list.

While Gold Royalty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report